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ABSTRACT

Age related macular Degeneration is a retinal condition resulting in visual
impairment and central vision loss caused by dysfunction of the Bruch’s membrane and
the retinal-pigmented epithelium. . A novel treatment idea proposes that these layers
may be repaired through replacement using a synthetic Bruch’s membrane, such as
modified poly(ethylene glycol) commonly known as PEG, allowing regrowth of the
RPE layer in vivo or through inclusion of a functioning RPE layer when implanting the
membrane. Modifying poly(ethylene glycol) with surface bound adhesion peptides such
as RGDS provides an excellent biomaterial scaffold in which RPE cells may repopulate
and regain their appropriate functions. The purpose of the proposed research is to
evaluate the efficiency of the surface bound adhesion peptide, RGDS, and the effect of
RGDS concentration on cellular confluency and morphology in both ARPE-19 and
PRPE cell lines on modified PEG hydrogels. Using fluorescent and confocal
microscopy, it was found that between 4 and 5 percent of the total coating solution was
effectively bound to the hydrogel surface. Cellular morphology using
immunocytochemistry staining of zonula occluden, or ZO-1, also demonstrated
morphological characteristics are obtainable using visual parameters such as cell
circularity. Even though differentiation was shown to be lacking when compared to
fibronectin controls, the results indicate that all concentrations tested proved effective
in providing optimal cellular confluency.
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I.

INTRODUCTION

Age-related macular degeneration (AMD) is a degenerative eye disorder that
commonly effects people over the age of 50 (National Eye Institute, 2009). It is the
leading cause of blindness in industrialized nations (Sun et al., 2001) This disease
affects over 1.75 million people in the United States and is expected to increase by 50%
by the year 2020 (The Eye Diseases Prevalence Research Group, 2004). Prevalence of
the disease also dramatically increases with age. An estimated 8 million Americans
over the age of 65 are at high risk to develop AMD, of which 1.3 million will develop
the condition within the next 5 years (National Eye Institute, 2011).
Multiple treatments are currently being developed for AMD within the field of
bioengineering (Lee et al., 2005)(Kubota et al., 2005)(Binder et al., 2004). One
proposed treatment removes the damaged Bruch’s membrane and replaces it with a
synthetic scaffold, which functions similarly to the membrane extracellular matrix
(Kubota et al., 2005). This allows introduction of a newly seeded Bruch’s membrane
(Kubota et al., 2005) or migration of cells from the healthy portions of the retina to
repair the diseased area (Binder et al., 2004). Of these scaffold materials, poly(ethylene
glycol) (PEG) is currently being pursued as a potential candidate due to its desirable
mechanical properties, ability to polymerize in situ, and inability to promote cellular
adhesion (Gombotz, 2004). PEG also has the ability to control its density and elastic
modulus by changing the concentration and molecular weight of the polymer, which
allows for the material to be specifically tuned for use in repairing this tissue (Brandl et
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al., 2007). Mann et al. (2001) demonstrated the ability to control adhesion on PEG
hydrogels using covalently modified peptide sequences, such as RGDS, for migration
and proliferation of smooth muscle cells; thus, enabling controlled tissue ingrowth.
However, to date, the majority of Bruch’s membrane substitute materials developed do
not provide the necessary signaling for controlled morphology; thus, there is a need for
an alternative solution.

A. Objective

The objective of this research is to create and characterize a substitute Bruch’s
membrane material using PEG hydrogels with varying concentrations of surface bound
RGDS to promote adhesion of the retinal pigmented epithelial (RPE) cells while
displaying morphology linked to a differentiated state.

B. Hypothesis

The hypothesis of this study is that increasing concentrations of RGDS on PEG
hydrogels will significantly promote morphological expression, including overall cell
coverage, cell circularity, cell area, actin filament length and actin filament orientation,
related to RPE-specific differentiation in both adult retinal pigmented epithelial
(ARPE-19) and primary RPE (PRPE) cell lines. This hypothesis has been evaluated by
the completion of the objectives and specific aims listed below.
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C. Specific Aims

Specific Aim 1-1: Quantification of PEG-RGDS Coating (Fluorescence)
PEG hydrogels were polymerized and coated with mixtures of RGDS and
RGDS-Fluor 488 at a 10:1 ratio. Coating concentrations of 20, 10, 5 and 0
µmol/mL were created and polymerized. Rinses from each individual gel were
then collected and analyzed using a fluorometer. This was used to determine an
average concentration of PEG-RGDS coating per cm2 for each coating level.

Specific Aim 1-2: Quantification of PEG-RGDS Coating (Confocal)
Also under specific aim one, RGDS-Fluor 488 coated gels were analyzed
using confocal microscopy to further observe gel coating characteristics,
homogeneity and deviation of the coating intensity between gel concentrations.

Specific Aim 2: Quantification of Cellular Confluency on Hydrogels
Surface coverage for PEG-RGDS hydrogels was also observed. This was
completed using phase contrast imaging for each coating concentration,
fibronectin control and RPE cell type. Images were analyzed using ImageJ
(Version 1.47; NIH 2004) and compared for significant differences.

Specific Aim 3: Determination of RPE Differentiation using ZO-1 Staining
In order to observe morphological properties of the RPEs on PEG-RGDS
coated hydrogels, each gel coating concentration, RPE line and controls were
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stained for ZO-1 using immunocytochemistry techniques. Images were obtained
using confocal microscopy and analyzed for circularity, area, cell perimeter and
aspect ratio in each selected cell using ImageJ. These parameters were then used
to compare gel groups and RPE lines to their respective fibronectin controls.

Specific Aim 4: Determination of RPE Differentiation using Actin Staining
Samples were also stained with rhodamine-phalloidin to obtain imaging of
actin filaments within the RPEs. Cells within each image were then selected and
analyzed using ImageJ to determine average actin filament length compared to
each sample group. Orientation of fibronectin controls were also compared with
the coated gels to further compare morphological properties of each group.

D. Significance of Study

This study is significant for a number of reasons. First, this is the one of only a
few studies focused on using poly(ethylene glycol) modified with adhesive peptides for
development of a synthetic Bruch’s membrane. Only one previous study based on the
same material is known, of which is the precursor to this study (Scherzer 2010).
Although this study is based on a previous idea, the method of material synthesis is
novel. This study focuses on the development of surface modified PEG hydrogels
compared to homogeneously distributed concentrations of adhesion ligands. This
technique allows for further refinement and control of the concentrations of peptide
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exposed, providing a more accurate quantification of the required amount of adhesive
ligand per gel area.
This study is also significant in the method used to compare morphology of RPE
cells. Using parameters based on cell staining such as circularity, area, perimeter and
aspect ratio allows for the introduction of more quantifiable parameters to determine
the amount of differentiation of a cell. This provides a numerical standard in which
further studies in RPE morphology can be compared to determine the closeness of the
confluent cell layer on the modified material to a more natural epithelial phenotype.
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II.

BACKGROUND

A.

Anatomy of The Eye

The eyes are highly complex organs of the body responsible for capturing light
and translating it into electrochemical impulses. As light enters the eye, it is focused
using the cornea and lens. This focused light passes through the vitreous humor and is
then projected onto the retina. At the retina, light is translated into optic nerve signals
by rods and cones. These signals are sent from the photoreceptors to the visual cortex in
the brain through the optic nerve and are then further interpreted into the sense of
vision.

1. General Eye Anatomy

A general anatomical representation of the eye is presented in Figure 1. The
general anatomy of the eye consists of three primary layers. The outer layer is
composed of the cornea, sclera and optic nerve. The cornea, along with the lens,
refracts light and allows for the eye to focus. It is composed primarily of connective
tissue and a thin surface epithelial layer (Shier et al., 2012). About two thirds of the
overall refractive power of the eye comes from the cornea, due to the high refractive
index differential from air (Guyton and Hall, 2011). The sclera is the protective fibrous
layer composed of disorganized elastic and collagenous fibers (Shier et al., 2012). The
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sclera also provides protection for the eye as well as an anchor point for extrinsic
musculature. The optic nerve is located in the back of the eye and transmits signals
from the rods and cones to the visual cortex in the brain.

FIGURE 1- Eye Anatomy (Larson Eye Center, 2012)

The choroid coat, ciliary body, lens and the iris form the middle layer of the eye.
The choroid is the vascularized section of the eye, allowing for nourishment of the
retina (Shier et al., 2012). It also contains melanocytes that absorb excess light within
the eye. The ciliary body is the thickest part of the eye and produces aqueous humor.
Suspensory ligaments also extend from the ciliary processes to anchor the lens into
position. These in combination with the ciliary muscles allow for the eye to focus by
altering the shape of the lens using tension. The lens itself lies directly behind the pupil
and is composed of epithelial lens fibers. The iris controls the overall amount of light
that reaches the retina. It is composed of mostly connective tissue and smooth muscle
fibers.
The innermost layer of the eye is the retina. This layer is the light sensitive
portion of the eye and allows for chemical signal transmission by converting the light
into electrochemical signals which traverse the optic nerve to the visual cortex. The
7

retina is mostly transparent to allow for absorption of light by the photoreceptors (Shier
et al., 2012). The retina is integrated with the optic nerve and the central area of the
retina is called the macula lutea. Within the macula lutea is the fovea centralis, which is
the region where the sharpest vision is produced. Medial to the macula lutea is the optic
disc, where nerve fibers from the retina join the optic nerve to transmit signals to the
visual cortex. Central arteries and veins also pass through the optic disc.
The retina can be divided into nine total layers (Guyton and Hall, 2012). Starting
from the inside of the eye is the inner limiting membrane. This layer functions as a
barrier between the retina and vitreous humor. The next layer is the ganglionic layer,
which contains ganglion cells within the retina that transmit signals from the retina to
the optic nerve.
After the ganglionic layer is the inner plexiform layer that contains interplexiform
cells which transmit negative feedback signals from the outer plexiform layer to the
inner plexiform layer (Guyton and Hall 2012). This feedback mechanism is believed to
control the spread of the visual signals by horizontal cells and control the degree of
contrast in an image.
Next are the inner nuclear and outer plexiform layers, which contain the nuclei of
the majority of cell types used in the transmission of visual signals from the
photoreceptors (Guyton and Hall, 2012). These cell types include horizontal, bipolar
and amacrine cells. Horizontal cells specifically transmit signals horizontally from the
rods and cones to bipolar cells. Bipolar cells transmit signals vertically from the
photoreceptors as well as horizontal cells to ganglion or horizontal cells in the inner
plexiform layer. Amacrine cells transmit signals in two directions, either from bipolar
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to ganglion or horizontally within the inner plexiform layer to other amacrine cells.
About thirty types of amacrine cells have been identified, with only about a half dozen
of these being characterized. Each of these amacrine types plays an important role in
visual signal stimulation, inhibition and analysis.
The outer nuclear layer contains the bodies of the photoreceptors. Below the outer
nuclear layer is the layer of rods and cones projecting to the pigment. Rods and cones
are the light sensitive portion of the eye with the rods controlling both light intensity
and black and white vision while the cones are responsible for color vision (Guyton and
Hall, 2012). When either of these photoreceptors are excited by a light wave
transmitted through the eye, an electrical impulse is generated which travels through the
connected nerve fibers, described above, and to the optic nerve fibers for final
translation into vision.
Both rods and cones can be broken into four functional segments; the outer
segment, the inner segment, the nucleus and the synaptic body. The outer segment
contains most of the light sensitive photochemicals. For the rods, the photochemical is
rhodopsin. For cones, one of three color pigments are used, all functioning in different
spectral areas. These pigments are red (erythrolabe), green (chlorolabe) and blue
(cyanolabe) (Shier et al., 2012). The inner segment contains the cytoplasm and its
respective organelles. The synaptic body connects to each of the different neuron types
within the retina.
Lastly, the pigmented layer prevents light reflection from within the eye via
increased levels of melanin, allowing for clear images (Guyton and Hall, 2012). This
layer also stores a large amount of vitamin A, used in the formation of rhodopsin.
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2. Retinal Pigmented Epithelium

Moving further through the retina, the next layer of specialized cells is the retinal
pigmented epithelium (RPE). This layer of cells acts as a functional intermediary
between the choroid and the neural retina (Grierson et al., 1994). RPEs are typically
brown in color due to deposits of melanin, lipofuscin and other pigments (Lu et al.,
2001) The high concentration of these pigments allow for absorption of light,
preventing reflection from within the eye (Mecklenburg and Schraermeyer, 2007). The
size of RPEs in vivo has been well documented and ranges between 10-60µm. (Roorda
et al., 2007)(Lu et al., 2001). This number can vary significantly with age as well as
location. Cells near the macula, the central portion of the eye, typically size within the
10-14µm range while the periphery has been measured up to 60µm (Lee et al., 2007).
This epithelial layer is intimately attached to the outer segment tips of the
photoreceptors on its apical side while the basal sides rest on a basement membrane
formed above the Bruch’s membrane (Grierson et al., 1994). RPEs are polarized and
involved in multiple activities vital to visual function, such as phagocytosis of used rod
and cone outer segments, metabolizing vitamin A, transporting metabolites and forming
the blood-retinal barrier (Grierson et al., 1994). Each RPE cell supports approximately
40 photoreceptors by transporting cellular metabolites as well as nutrients from the
choricocapillaris (Forrester et al., 2002).
In order to form a functional blood-retinal barrier, zonula occluden, commonly
known as tight junctions are formed between RPE cells to prevent leakage through the
intercellular spaces (Grierson et al., 1994). Another essential junction includes zonulae
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adherens, or intermediate junctions, which promote adhesive properties and
maintenance of the polygonal shape of RPEs as well as help organize the superficial
web of actin microfilaments (Sandig and Kalnins, 1988). Gap junctions allow for lowresistance pathways of ions and metabolites between the cells (Hudspeth and Yee,
1973). Actin structure also plays an important role in the morphology of RPE cells.
Actin is involved in many cellular processes, including establishing morphology,
migration, organelle transport, cellular division and support of cell-cell junctions (Karp
et al., 2008). Actin distribution is commonly used for evaluation of RPE morphology
(Burke et al., 2008). This is due due to its circumferential orientation around epithelial
RPE cells (Lee, Fishman and Bent, 2007). Re-organization of RPE cells from a
migratory to epithelial state includes reorganization of actin filaments into peripheral
bands (Burke et al., 2008).
These cells are derived from the neuroepithelial cells of the neural plate during
development and transdifferentiation into neuroretinal tissue is rapidly lost in
mammals, although fibroblast growth factor (FGF) has been shown to stimulate
neuroretinal regeneration in chick embryos (Grierson et al., 1994). Interestingly
enough, RPE have been shown to transdifferentiate past development in salamanders as
iris or lens epithelium. (Grierson et al., 1994). Not only do RPEs contribute to the
formation of the Bruch’s membrane, but also to the development of the scleral coat
(Grierson et al., 1994). Photoreceptor outer segments have also shown not to develop
until contact between the neural and epithelial layers are established by the RPE
(Hollifield and Witkovsky, 1974).
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RPE cells are extremely limited in replicative ability in situ. It is believed that
inhibition is caused by the gap junction system (Grierson et al., 1994). Since these cells
are suspended in proliferation by contact inhibition, RPE expansion depends on the
enlargement of individual cells. This is especially the case around the periphery, where
multi-nucleated RPE cells can measure up to 60 µm in diameter compared to the typical
14 µm (Grierson et al.,1994). Once contact inhibition is removed due to injury,
proliferation of the RPE layer will resume.
Two phenotypic styles of RPEs can form following injury. One form resembles
morphology of a large macrophage while the other is elongated, bipolar and fibroblastic
(Grierson et al., 1994). Macrophage forms are typical in cases of proliferative
vitroretinopathy (PVR) and inhabit the vitreal cavity. These phenotypic expressions in
altered circumstances rapidly revert to an epithelioid phenotype, meaning the changes
in morphological properties is only metaplasia (Grierson et al., 1994). Once regions of
high density and tight packing are obtained, gap junctions form between the adjacent
cells. Extracellular matrix (ECM) materials are also synthesized, such as fibronectin
(Grierson et al., 1994). Although RPEs may revert back to epithelioid morphologies,
establishing an effective mosaic proves to be more difficult both in vitro and in vivo. In
culture, RPEs often lose pigmentation and do not usually re-pigment until weeks post
confluency (Burke et al., 2008). This extended restructuring process is also seen in Ncadherin formation at cell-cell junctions (McKay et al., 2007). Both N-cadherin and Ecadherin concentrations were shown to be consistent between fibroblastic and epithelial
phenotypes, but were reorganized depending on the morphology (McKay et al., 2007).
When observing changes in actin structures, settled RPEs produce a diffuse pattern
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around the periphery while migratory forms produce filamentous fibers and finally
organized stress fibers when stationary. Stress fibers are also common of normal RPEs
in situ as well as in immobile, adherent cells in vitro (Grierson et al., 1994). Cytokeratin
expressions also change dramatically during morphological changes. In situ, RPE cells
express K8 but lack larger forms such as K18 and K19, yet these are expressed by
migratory fibroblastic RPEs (Grierson et al., 1994).
Substrate seems to be a crucial role in determining the morphological response of
RPEs. The macrophage phenotype has been shown to develop when placed in an
aqueous environment, photoreceptor debris, in the subretinal space or on loose collagen
fibrils in the vitreous (Grierson et al., 1994). The fibroblast form typically generates on
two-dimensional surfaces at low densities and when the surface is rich in fibronectin.
This is known from studies of epidermal repair where fibronectin is abundant while
cells are migratory, whereas laminin becomes the dominant protein after repair. Under
crowding conditions and in the absence of fibronectin, an epithelioid type is readily
adopted (Grierson et al., 1994). Maintenance of polarization also seems to be reinforced
by metabolite transport and phagocytosis. Retinoids may also have growth-inhibiting
properties as well as indirect influence on cytoskeletal structure (Grierson et al., 1994).

3. Bruch’s Membrane

The Bruch’s membrane is an integral part of the eye. This cellular basement
membrane is a pentalaminar structure composed of a central elastin layer with
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collagenous zones on both sides, forming a 2-4µm thick boundary layer between the
RPE layer and the choroid (Lee et al., 2006). Its main function is to transport nutrients
from the blood supply to the RPE layer and allow for removal of waste products back
to the choricocapillaris. This layer also plays an integral part in maintaining the bloodretinal boundary and increasing the stability of the neighboring layers (Aisenbrey et al.,
2006).
In general, the Bruch’s membrane is predominantly composed of glycoproteins,
much like most basement membranes. The overall glycoprotein composition of the
membrane includes collagen I and IV, laminin, fibronectin and elastin (Marshal et al.,
1998). This combination of glycoproteins also plays in integral role in the signaling and
polarization of the RPE layer (Grierson et al., 1994).The Bruch’s membrane is also
ultrastructurally and biochemically similar to other membrane complexes such as the
glomerulus, lung alveoli and other endothelial-epithelial juxtapositions (Sheridan et al.,
2004).
The surface of the Bruch’s membrane closest to the RPE layer is known as the
RPE basal lamina. This layer functions as the attachment surface for the RPE layer (Del
Priore, Tezel and Kaplan, 2006). Removal of the basal lamina and the inner
collagenous layer from the Bruch’s membrane due to disease or damage has been
shown to prevent re-epithelialization by RPEs, making resurfacing of aged Bruch’s
membranes difficult (Del Priore, Tezel, Kaplan, 2006).
It is at the Bruch’s membrane that the introduction of multiple factors such as
drusen accumulation and vascularization begins to occur, causing blurred and distorted
vision. This indicates the initiation of a disease referred to as macular degeneration.
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FIGURE 2- Bruch’s Membrane in relation to RPEs and choroid (Luthert 2010)

B.

Macular Degeneration

Age-related macular degeneration is one of the most significant causes of central
vision loss and blindness in industrialized countries (Ma et al., 2009). Although this
disease has been studied extensively, some of the pathological changes associated with
initiating the disease are still not fully understood. The disease in general causes central
vision loss related to aberrations between the RPE and the Bruch’s membrane. This loss
in central vision is due to progression of the disease within the macula lutea. Diagnosis
of the disease is usually conducted using a visual acuity test such as an Amsler grid
(Doheny Eye Institute, 2007). Missing lines, distortions or blurred vision when using an
Amsler grid can be indicators of AMD.
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FIGURE 3- Amsler grids. Left photo indicates normal vision while the right simulates AMD.
(National Eye Institute 2009)

1. Pathology

There are two predominant forms of AMD; the wet and dry form. The wet form
of AMD, also known as exudative AMD, consists of formation of new blood vessels
between RPEs and the Bruch’s membrane and a loss of RPE cells (Lee et al., 2006).
This is known as choroidal neovascularization (CNV). CNV is thought to be the cause
of 90% of the visual impairment tied to AMD (Del Priore et al., 2006) and leads to
scarring of the retina, preventing re-epithelialization by the RPE. Dry AMD, known as
geographic atrophy, is linked to the natural thinning of the macula over time (Luthert et
al., 2010).
When dysfunction of the RPE layer begins, degradation of photoreceptor waste
products may begin to decrease, leading to drusen accumulation (Zarbin et al., 1998).
Both drusen and CNV separate the basal lamina from the inner collagenous layers,
distorting the RPE and photoreceptor layers above, causing visual impairment (Del
Priore, Tezel, Kaplan, 2006). This increase in the Bruch’s membrane thickness leads to
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a reduction in permeability, further inhibiting metabolite removal and nutrient diffusion
(Lee, Vroom, Fishman and Bent, 2006). Drusen formation may also increase the risk
and progression of CNV (Del Priore, Tezel, Kaplan, 2006). This drusen formation is
often found in the inner collagenous layer as well as the basal lamina of the Bruch’s
membrane (Del Priore, Tezel, Kaplan, 2006).
Drusen are categorized by size and shape (Mecklenburg and Schraermeyer, 2007).
Hard drusen typically less than 125 µm wide and are well defined; soft drusen is
typically more diffuse, less defined visually and carry a higher risk of progression of
AMD (Luthert et al., 2010). Hard drusen appear to contain a dendritic cell process,
have well defined edges and appear more frequently between the choricocapillaris and
capillaries. Due to use of conflicting terminology in past publications concerning
diffuse deposits, more recent categorizations based on location have been created.
These categories are based on deposits internal to the RPE basement membrane laminar
deposit (BlamD) and those external to the RPE basement membrane linear deposit
(BlinD). BlamD contains abundant ‘long-spaced collagen’ similar to type VI collagen
while BlinD contains more membranous material (Luthert et al., 2010).
Growth factors may also play an important role in the progression (and potential
inhibition) of AMD. Pigment epithelium-derived factor (PEDF) and Thrombospondin-1
(TSP-1) are produced by highly differentiated RPEs and are potent inhibitors of
angiogenesis (Ohno-Matsui et al., 2001) (Miyajima-Uchida et al., 2000). Vascular
endothelial growth factor (VEGF), a pro-angiogenic growth factor, has also been shown
to be produced by RPE cells on their basal side in vivo (Blaauwgeers et al., 1999). With
RPEs and the Bruch’s membrane in their natural forms, secretions of these growth
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factors allow for physiological maintenance of the choroid. Damage such as oxidative
stress may cause overexpression of growth factors by the RPEs, causing a proinflammatory response and a destruction of the Bruch’s membrane (Koh, 2000).
Hypoxia may also play a role in the development of CNV. Hypoxia markedly
increases VEGF secretion, increasing the drive of CNV and causing a positive feedback
mechanism (Blaauwgeers et al., 1999). A decrease in Bruch’s membrane permeability
due to age or drusen accumulation may also decrease the concentration of VEGF
exposed to the choricocapillaris, resulting in vascular atrophy (Schlingemann et al.,
2004).
Proper diagnosis can also become a complication for early stages of AMD, as it
can be difficult to distinguish normal aging and pathologically significant physiological
changes. Differences between normal ECM debris and drusen can be difficult to
differentiate between (Del Priore et al., 2006). Normal physiological changes related to
aging such as increasing thickness, deposition of ECM compounds and protein crosslinking may be indistinguishable from early stages of AMD (Gullapalli et al., 2005). On
order to appropriately diagnose early AMD, further research must occur in order to
accurately distinguish the disease state from the normal aging process.

2. Current Treatments

Relatively few treatments have been proven effective for treating wet AMD. One
of the most commonly used is that of anti-VEGF treatments. Of these, ranibizumab,
bevacizumab and aflibercept are the most common and approved by the FDA.

18

Ranibizumab, also known as Lucentis, is commonly used for treatment of wet AMD,
diabetic macular edema and macular edema following retinal vein occlusion.
Ranibizumab is a monoclonal antibody fragment that binds to the receptor binding
domain of all isoforms of VEGF-A (Browning et al., 2012). During clinical trials,
ninety-four percent of patients maintained their current vision while almost thirty-four
percent experienced an increase in visual acuity within one year given monthly doses
(Rosenfield et al., 2006). Bevacizumab, also known as Avastin, is also a monoclonal
antibody similar to ranibizumab, but uses a full-length antibody instead (Browning et
al., 2012). Aflibercept, known as Eylea, is a newer anti-VEGF drug to come to the
market which specifically binds to VEGF-A, VEGF-B and placental growth factors 1
and 2 and is reported to have a higher binding affinity than both ranibizumab and
bevacizumab (Browning et al., 2012).
Another treatment for exudative AMD is thermal laser coagulation, which only
restricts the progression of the disease rather than treating it (Del Priore et al., 2006).
Unfortunately, this treatment also causes undesirable side effects such as scotoma due
to destruction of the retinal tissue around the treatment area. Also, using this treatment
method does not prevent further CNV from occurring in a large number of patients (Del
Priore et al., 2006). Brachytherapy in combination with anti-VEGF medications have
also been studied (Avila et al., 2009). This treatment used a single strontium-90
radiation treatment along with two injections of bevacizumab and was able to obtain
similar results as monthly doses of anti-VEGF medications alone (Avila et al., 2009).
Side effects for this treatment included CNV leakage in one fifth of patients as well as
cataracts in a quarter of patients. In general, all of these treatments are used to prevent
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progression of the disease. Further research in the development and progression of the
disease must be done in order to develop a restorative treatment.
In addition to treatments for AMD, education on potential preventative measures
is highly important, especially for those that may have a significant risk of developing
the disease. Many dietary supplements such as lutein, vitamins C and E, zinc,
glutathione and zeaxanthin are thought to be helpful in preventing early onset of CNV
associated with AMD (Nowak et al., 2006). Smokers have also been found with
significantly less macular pigment, leading to a risk increase by a factor of two to three
times (de Jong et al., 2006). Omega-3 fatty acid intake has also been associated with a
lower risk of AMD (Ambati et al., 2012). Even though taking these supplements may
help reduce the risk of developing the disease, none of these treatments are proven to
prevent the disease.
In developing restorative treatments for the disease, multiple maculoplasty
techniques have been tested to reintroduce functional RPEs to an excised or repaired
section of Bruch’s membrane. These techniques use either transplantation,
translocation, stimulation or cell proliferation to repair the damaged membrane (Del
Priore et al., 2006). Submacular surgeries including membranectomies have shown
some progress in past studies, but RPEs often showed incomplete resurfacing as well as
choricocapillaris atrophy in areas absent of RPE.
Currently, there have been limited successes with direct injection or
transplantation of RPE sheets into the eye to repair damaged Bruch’s membranes
(Binder et al., 2004). Often after transplantation, multilayered sheets of RPE cells have
formed, developing an improper orientation of cells with respect to the photoreceptors.

20

Even with proper orientation, RPE adhesion may be lacking (Del Priore and Tezel,
1998). Patients must also be immunosuppressed to allow for allogenic cellular grafting
(Jiang and Jorquera, 1994). Patients with subfoveal membranectomies and
transplantations of adult human RPEs, even with immunosuppression, have had limited
success (Kaplan and Del Priore, 1998).
RPE monolayers have also been suggested for transplantation into excised areas.
By using temperature responsive materials, sheets of confluent RPE cells were obtained
(Kubota et al., 2006). Due to the thin nature of the material, most sheets obtained some
damage during removal from culture. Although this study proves the feasibility of
generating these cell sheets, further research is still needed on creating more robust and
transplantable sheets while maintaining viability and function in vivo.
Biodegradable polymers have also been proposed as a replacement for damaged
Bruch’s membrane. Materials such as poly(lactic acid) (PLA) and poly(DL-lactic-coglycolic acid) (PLGA) have been proposed as suitable membrane replacements due to
their biocompatibility and degradability (Lu et al., 2001). In theory, cells would be
seeded onto thin sheets of the material in vitro and allowed to reach confluency. The
sheet would then be loaded into a micropipette and carefully injected into the damaged
area. Cells would then attach themselves to the existing Bruch’s membrane after
degradation of the material at two to three weeks (Lu et al., 2001). Due to the fragile
nature of the RPE monolayer, it may be difficult to transplant a complete monolayer of
these cells using this technique. This technique also assumes that the remaining RPE
layer would inherently attach to the remaining Bruch’s membrane, although previous
studies have not shown much success (Del Priore et al., 2006) (Gullapali et al., 2005).
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A variety of other materials have been suggested as replacement for Bruch’s
membrane such as collagen films, Bruch’s membranes from cadavers, anterior lens
capsule, Descemet’s membrane and amniotic membranes (Lee et al, 2007). Although
many different substrates have been proposed, no material studied so far has been able
to successfully produce a fully functioning membrane for replacement.

3. Proposed Solution

In developing new treatments for AMD, it is important to understand that the
replacement Bruch’s membrane must be of comparable thickness, similar permeability
and provide an effective cellular scaffold in which to support the native RPE layer (Lee
et al., 2006). The material must also be a permanent replacement for the native Bruch’s
membrane, providing enough similar mechanical and chemical responses as to allow
the RPE layer above to maintain a functioning membrane. The replacement membrane
could also potentially provide chemical cues such as VEGF to sustain the
choricocapillaris until a functioning RPE layer is obtained.
The concept this research is based upon focuses on the development of a
permanent, synthetic Bruch’s membrane. This synthetic membrane would mimic the
natural functions of the Bruch’s membrane such as adequate permeability for the
diffusion of nutrients and metabolites, comparable mechanical strength as well as
biological molecules to promote RPE adhesion and differentiation. (Del Priore et al.,
2006). PEG hydrogels meet the requirements for a suitable membrane in these areas,
but it is known for its poor ability for cell adhesion. In order to alleviate this problem,
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PEG gels modified with adhesion ligands on the surface layer have been developed to
provide cellular adhesion to the apical side of the gel. With proper concentrations of
ligands, these gels would allow for adequate adhesion of RPE cells to promote
confluent coverage as well as appropriate epithelial morphology. This research is
focused on obtaining an optimal concentration of surface adhesion peptides to allow for
appropriate RPE development based on ZO-1, actin expression, and other factors such
as cell circularity, area and actin orientation. All gel concentrations will be compared to
fibronectin coated glass coverslips as a positive control while PEG only hydrogels will
function as negative controls. Both ARPE-19 and PRPE cell lines will also be used in
order to evaluate the differences in immortalized and primary RPE cells when seeded
on these gels.

C.

Hydrogels

1. Hydrogel History

Hydrogels are water-insoluble polymers which absorb a large amount of water.
These polymers can be derived from both natural and synthetic materials and are used
in a variety of fields (Society for Biomaterials, 2007). Hydrogels have been used in
biomedical disciplines for over fifty years in areas such as ophthalmology and surgery
(Gibas et al., 2010). The first hydrogel developed for potential biomedical use was
poly-2-hydroxyethyl methacrylate, originally used for soft contact lenses (Gibas et al.,
2010). In the 1980s, calcium alginate was developed for creating microcapsules for
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cellular engineering (Gibas et al., 2010). Hydrogels today are often used in prevention
of thrombosis, drug delivery, post-operative adhesion, biosensor coating, cell scaffolds
and transplantation (Gibas et al., 2010)(Brandl et al., 2007).
In order to absorb large quantities of water without dissolving, hydrogels are
crosslinked using chemical or physical means. This allows the material to maintain
integrity when placed in a solution. In order to develop these crosslinks, hydrogels are
commonly bound together using cross-linking agents such as succinimidyl ester amine
modification or using free radical polymerization. One common technique used to
create hydrogels in situ is photopolymerization, which uses a light to generate a free
radical reaction with a crosslinking reagent to combine two polymers. Use of this
technique allows spatial control, curing speed control and minimal heat production
(Gibas et al., 2010).

2. Poly(ethylene glycol) Hydrogels

PEG hydrogels are well known for their biocompatibility and optical transparency
(Brandl et al., 2007). Their ability to form semi-permeable membranes and large
aqueous content make them a strong candidate for a synthetic Bruch’s membrane.
Other factors such as mechanical stiffness and functional modification also help
promote their use in biomedical applications (Brandl et al., 2007). This versatility of
PEG is made possible by first functionalizing the ends of the PEG hydroxyl chains in
order to allow them to bind to one another (if the original hydroxyl groups are not
used). Both ends of the chain can be either purchased or synthesized with the same or
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different functional groups to allow for further control of how the polymer crosslinks to
other chains.
There is only one caveat to the use of PEG hydrogels for the use of a synthetic
Bruch’s membrane; its inability to promote cellular adhesion (Gombotz, 2004). This
can be resolved by incorporating functional PEG groups that promote cellular adhesion.

FIGURE 4 - Poly(ethylene glycol) (Ozden 2012)

An excellent example of using different functional groups with this polymer are
ligand modified PEG polymers. The use of modified PEG hydrogels with attachment
ligands is very well documented (Patel et al., 2005). Ligands such as YIGSR and
RGD(S), peptide segments of laminin and fibronectin, respectively, are commonly used
to promote cellular adhesion to materials. These PEG-peptide polymers have been used
with multiple cell types such as smooth muscle cells and preadipocytes (Mann et al.,
2001) (Patel et al., 2005). Attachment and migration has also been studied using
fibroblasts on modified PEG hydrogels (Gobin and West, 2002). Using specific
attachment ligands also promotes specific cellular adhesion (Mann et al., 2005).
Specific placement of these attachment molecules also add a spatial component to the
synthesized gel, allowing for specific cell targets to bind in certain areas while
preventing adhesion in another.
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D.

Adhesive Ligands

Many cell types are known to use different adhesion ligands in order to interact
with the space around them. Integrins and laminins are often used as cues to promote
cellular attachment (Aisenbrey et al., 2006). Integrins are trans-membrane proteins
that specifically function as adhesion receptors for cells (Takada et al., 2007). These
receptors bind to ligands in the ECM, a cell surface or in the extracellular solute
(Takada et al., 2007). Ligands are heterodimeric and are composed of an α-subunit
and a β-subunit (Aisenbrey et al., 2006). There are currently eighteen known αsubunits and eight β-subunits, forming twenty-four unique combinations that have
characterized so far (Takada et al., 2007). For RPEs, integrins α3β1, α6β1 and α6β4
have significant interactions regarding cellular attachment (Aisenbrey et al., 2006).
Commonly, integrins will interact with a variety of extracellular proteins, such as
fibronectin and laminin (Boateng et al., 2004).
With respect to RPE cells, it has been found that adding adhesion ligands such as
laminin, fibronectin and vitronectin to aged Bruch’s membranes promote attachment
when compared to non-treated membranes (Tezel, Del Priore and Kaplan, 2004). This
proves that in order to appropriately replace functional RPE cells, a layer of
attachment ligands is required. Previous studies have also shown that RPE cells will
adequately adhere to coatings of fibronectin as well as PEG-RGDS hydrogels
(Scherzer ,2011). Although PEG-RGDS has been proven as an adhesion ligand, it is
possible that it may alter cellular function and morphology (Boateng et al., 2004). In
order to unveil whether or not this is the case with RPE cells, this research is focused
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on observing morphological properties such as cell circularity, ZO-1 expression and
actin filament length to ascertain if RPE cells remain differentiated.

1. RGDS

RGDS, the amino acid sequence Arg-Gly-Asp-Ser, is a well-known peptide found
in the tenth domain of fibronectin and is highly involved in cellular attachment
(DeLong et al., 2005). The modification of PEG hydrogels with this peptide sequence
has also been studied extensively with human dermal fibroblasts (Gobin and West,
2002)(Hahn et al., 2006) as well as with RPE cells (Scherzer, 2010). RGDS
immobilized films have also been shown to be more stable against heat treatment and
enhance cellular growth better than fibronectin films (Ito et al., 1991). Some sources
are commonly found referring to the RGD sequence in respect to cellular attachment.
Studies have found that when using three different versions of RGD- RGDS, RGDV
and RGDT, the RGDS was found significant in cellular attachment across five different
cell tpyes (Hirano et al., 1993).
RGDS has also been shown to stimulate TGF-β1 sectetion in human mesangial
cells when bound to integrins (Ortega-Velazquez et al., 2003). TGF-β1 has also been
linked to proliferation of RPE cells via epithelial-mesenchymal transition (Li et al.,
2011). This shows that using RGDS as an attachment ligand will promote RPE
proliferation into non-confluent sections of a coated gel.
The research herein will determine whether or not varied concentrations of PEGRGDS (0, 5, 10 and 20 µmol/mL) applied during the gel coating process will affect the
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deposited surface concentration on PEG hydrogels. Each concentration will then be
analyzed using phase contrast and confocal microscopy for differences in cellular
attachment and morphology to determine if an optimal concentration of PEG-RGDS
can be applied to encourage appropriate RPE expression.
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III.

METHODS AND MATERIALS

In this study, poly(ethylene glycol) (PEG) hydrogels were used as the substrate
material to mimic the Bruch’s membrane. PEG hydrogels were modified with different
concentrations (0, 5, 10 and 20 µmol/ml) of RGDS adhesion peptides. The effectiveness
of cell adhesion and confluency was measured using both optical microscopy and
confocal microscopy techniques. To determine morphological differences, ZO-1 and
actin were stained and imaged via fluorescence and immunofluorescence using confocal
microscopy. The step-by-step procedures and protocols used to fabricate these materials,
culture the cells on the biomimetic materials and image these substrates is presented in
detail below.

A.

Cell Culture

Previous studies have indicated that immortalized cells may behave differently
than primary lines, especially in RPE cells (Ablonzsky et al., 2011). These differences
can be observed in a multitude of ways, such as the morphological distribution of ZO-1
and actin. In order to determine the effects of RPE cell type when using PEG-RGDS
coated hydrogels, both immortalized ARPE-19 and primary PRPE cells were used for
this study.
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1. ARPE-19

Adult retinal pigmented epithelial cells (ARPE-19, Retinal Epithelium, Human;
ATCC; Manassas, VA; Item # CRL-2302) are a spontaneously immortalized cell line
created by Dunn et al. (Dunn et al., 1996). Cells were incubated at 37°C with 5% CO2
and cultured in T-75 culture flasks (75 cm2 Cell Culture Flask; Tissue Culture Treated
with Vent Cap; Corning Inc.; Item # 430641) using Dulbecco’s Modified Eagle
Medium: Nutrient Mixture F-12 (DMEM/F-12; Corning Inc; Item # 10-092-CV)
containing 10% fetal bovine serum (FBS; Gibco; Invitrogen; Item # 26140-079) and
1% Penicillin, Streptomycin and L-Glutamine (PSG; 10,000 IU/mL penicillin,
10,000μg/mL streptomycin, 29.2mg/mL glutamine; Cellgro; Mediatech; Item # 30-009CI) and fed 12mL three times a week. This media along with bovine serum was chosen
in order to encourage proliferation of cells, which has been successfully used by other
labs in culturing this cell type (Aisenbrey et al., 2006).
Once plated, cells were allowed to grow a minimum of two weeks postconfluency in order to obtain adequate cell densities with a majority of epithelioid
phenotype. To passage, Trypsin-EDTA (Trypsin-ethylene diamine tetra acetic acid;
Cellgro; Mediatech, Inc.; Item No. 25-052-Cl) was heated in a water bath at 37°C then
2mL were added per T-75 culture flask after first aspirating the used media and rinsing
once with PBS. The flask was then allowed to incubate for 10 minutes. After the cells
detached from the flask, 5 mL of media was added to deactivate any residual trypsin
and the cell suspension was moved into a 15mL centrifuge tube. The centrifuge tube
was then centrifuged for ten minutes at 1000 rpm (Beckman Coulter Allegra 6R
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Centrifuge). Residual media was aspirated from the cell pellet and the cells are resuspended in media. Cells were typically passaged at 1:6 and passages 11-12 were used
for these studies, although passage numbers for immortalized cell lines are insignificant
since they do not change characteristically between passages.

2. PRPE

Porcine retinal pigmented epithelial cells (PRPE) were obtained from primary
cultures from Qun Zeng, a postdoctoral researcher from the Tezel Lab in the
Department of Ophthalmology and Visual Sciences. This cell type was cultured under
similar conditions as ARPE-19 cells. However, the primary cultures were only
passaged once to ensure adequate ZO-1 expression and decrease risk of
dedifferentiation prior to seeding on gels. Cells were allowed to grow a minimum of
one-week post-confluency to ensure proper epithelioid phenotype.

B.

PEG-DA Synthesis

Poly(ethylene glycol) (PEG) (MW 6000; EMD; Item # PX1286L-4) was weighed
out in a glass beaker and then lyophilized overnight to remove any water from the
sample. All necessary glassware was dried overnight at 100°C. Synthesis begins by
adding PEG to a round bottom flask thrice evacuated and filled with argon. The flask
was then evacuated and filled again with argon. Up to 40 mL of anhydrous
dichloromethane (DCM; Sigma; Item # 270997) was added 10 mL at a time via glass
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syringe. Enough anhydrous DCM was used to make a non-viscous solution. The
evacuation process was once again repeated with argon. Triethyl amine (TEA; Sigma;
Item # 90335) was then added to the solution at a 2:1 molar ratio and allowed to mix
for five minutes. TEA acts as a catalyst by binding to free hydroxyl groups. After
repeating the evacuation process, acryloyl chloride (Sigma, Item # A24109) was added
slowly to the flask at a 2:1 molar ratio. Acryloyl chloride reacts with bound TEA on
PEG to create acrylate end groups. The solution was then evacuated with argon and
allowed to react overnight.
After allowing the mixture to react for at least 12 hours, the phase separation
process begins. The PEG mixture was moved into a 500mL separatory funnel. 2M
potassium carbonate (K2CO3; Acros; Item #42408) was added to the mixture to wash
the solution. The funnel was then sealed and shaken, venting after every fifteen to
twenty seconds. This process was repeated until no more CO2 was released. Parafilm
was then placed on the separatory funnel in place of the stopper and allowed to separate
for 24-36 hours. This separation allows for the separation of KCl into the aqueous
phase and the PEG-DA into the organic phase.
Next was the purification process. After allowing the organic and aqueous phase
to separate, the denser organic phase was drained into a separate beaker. Magnesium
sulfate (MgSO4; Fisher; Item #M65-500) was added as a drying agent while stirring the
organic phase. The mixture was then filtered using a vacuum flask and a Buchner
funnel with the filter paper pre-wet with DCM to remove the MgSO4. Diethyl ether
((C2H5)2O; Sigma; Item #673811) was then added to the remaining PEG solution in a 2
L beaker to precipitate the PEG-DA out of solution. The precipitate was then filtered
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using a Buchner funnel and paper pre-wet with ether. The PEG-DA powder was then
dried overnight under vacuum, dialyzed overnight in a 3500 Dalton molecular weight
membrane (Spectra/Por 7 Dialysis Membrane; molecular weight cutoff 3500; Spectrum
Laboratories; Item # 132111) in deionized water and sequentially lyophilized
overnight. The resultant PEG-DA powder was stored under argon at -20°C.

C.

PEG-RGDS Synthesis

PEG-RGDS was synthesized using a combination of monoacrylated PEG
succinimidyl valerate at 3400 dalton molecular weight (Acrylate-PEG-SVA; Laysan
Bio; Item # ACRL-PEG-SVA-3400-1g.) and RGDS peptide (H-Arg-Gly-Asp-Ser-OH;
Calbiochem; Item # 03-34-0002-25MG.) at a 1:1 molar ratio. These are first dissolved
separately in 50mM sodium bicarbonate (NaHCO3; Mallinckrodt Chemicals; Item #
7412-12) in deionized water at a minimum pH of 8.5. The dissolved RGDS was then
added dropwise to the Acrylate-PEG-SVA solution and was allowed to mix on an
orbital shaker in a centrifuge tube wrapped in foil for a minimum of four hours. The salt
and SVA ester was removed from the solution by dialysis using a 3500 Dalton
molecular weight cutoff membrane (Spectra/Por 7 Dialysis Membrane; molecular
weight cutoff 3500; Spectrum Laboratories; Item # 132111). The residual PEG-RGDS
solution was then lyophilized overnight. The resultant PEG-RGDS powder was stored
under argon at -20°C.
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D.

PEG-RGDS-Fluor 488 Synthesis

PEG-RGDS-Fluor 488 was synthesized in a method similar to PEG-RGDS. PEGRGDS was either allowed to conjugate in the sodium bicarbonate solution as explained
above, or was added back into sodium bicarbonate solution of the same strength (50
mM, pH 8.5 minimum). AlexaFluor 488 carboxylic acid, succinimidyl ester
(AlexaFluor 488 carboxylic acid, succinimidyl ester; Invitrogen; Item # A20000) was
then added dropwise to the PEG-RGDS solution at a molar concentration of 10:1
(AlexaFluor 488:PEG-RGDS). The mixture was allowed to react for a minimum of four
hours on an orbital shaker while wrapped in foil. The salt and residual AlexaFluor 488
dye was removed from the solution by dialysis using a 3500 Dalton molecular weight
cutoff membrane (Spectra/Por 7 Dialysis Membrane; molecular weight cutoff 3500;
Spectrum Laboratories; Item # 132111). The residual PEG-RGDS-Fluor 488 solution
was then lyophilized overnight. The resultant PEG-RGDS-Fluor 488 powder was stored
under argon at -20°C wrapped in foil.

E.

PEG-DA Hydrogel Formation

Molds for gels are preassembled using glass coverslides (25mm x 75mm x 1mm;
VWR; Item # 48300-025), 0.5 mm electrophoresis spacers (Fisher; Item # FBVE1033)
and binder clips (Staples, Item # 831610). Silicone vacuum grease (Dow Corning;
Sigma; Item # Z273554-1EA) was used to seal the mold and the molds are sterilized
overnight using a UV light. PEG-DA hydrogels are polymerized using 10% w/v PEG-
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DA in (10mM) HEPES. Twenty microliters of acetophenone photoinitiator (2, 2dimethoxy-phenyl-acetophenone; Sigma; 196118-50G) at 200mg/mL in Nvinylpyrrolidone (NVP; Acros Organics; CAS # 88-12-0) was added per milliliter of
PED-DA solution. The solution was then filter-sterilized using a 0.22µm PES syringe
filter (Millex-GP; Millipore Corporation; Item # SLGP033RS) in the biological laminar
flow hood. Approximately 1.5 mL of PEG-DA solution was then injected into each
mold and was polymerized for 1 minute using a 5mW 365nm UV light (Blak-Ray
B100-A; Fisher). The molds are then opened to expose the gel sheets and circular gels
are punched using a #5 (10mm) hole punch. Four gels were prepared for each peptide
concentration group (0, 5, 10 and 20 µmol/mL) described below in the next section.
Gels are then allowed to swell in PBS for a minimum of one hour at room temperature.

F.

Hydrogel Coating Procedure

PEG-DA hydrogels are surface modified with PEG-RGDS using either 5, 10 or
20 µmol/mL solution concentrations of PEG-RGDS. These solutions are made by
weighing out the desired amount of PEG-RGDS for a 20 µmol/mL solution and adding
the powder to 10mM HEPES. Enough solution was made to serial dilute and create the
other required concentrations. Photoinitiator was then added at a ratio of 20 µL per mL
of PEG-RGDS solution. The solution was then filter-sterilized using a 0.22µm PES
syringe filter (Millex-GP; Millipore Corporation; Item # SLGP033RS) in the biological
laminar flow hood. Non-coated gels are prepared by placing the gels to be coated onto
coverslides and removing any residual PBS. Ten microliters of the desired
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concentration of PEG-RGDS is then added to the top of each gel and is covered using a
24 x 60 mm coverslip (VWR; Item # 48393-106). This was determined based on the
amount of solution required to completely coat the surface of the gel. The gels are then
polymerized for 3 minutes using a 5mW 365nm UV light (Blak-Ray B100-A; Fisher).
Each gel was then placed into a 24-well culture plate (Corning Costar; Sigma; Item #
CLS3524-100EA) and rinsed with 500 µL of PBS.

G.

Quantification of Peptide Coating Using Rinse Supernatant

After PEG-DA hydrogels are surface modified with PEG-RGDS-Fluor 488 using
the same technique as described in section F above. In this instance, gels are coated
with a 10:1 ratio of PEG-RGDS to PEG-RGDS-Fluor 488 using the same total
concentrations (20, 10 and 5 µmol/mL). These gels are polymerized individually in 12well plates and covered with a 12mm coverslip to ensure a flat coating (Fisher; Item #
12-545-80). After polymerization and the initial PBS rinse of 500µL, each gel was
rinsed twice at 4 and 24 hours after polymerization to remove any non-grafted peptide
conjugate. All three rinses are collected cumulatively from each individual gel.
PEG-RGDS-Fluor488 coating fluorescence standards are also made by adding
5µL of each coating concentration in wells of a 24-well plate, covering with a 12mm
coverslip and exposing to UV along with the coated gels. 750µL of PBS was then
added to each standard to equal 100% coating solution concentrations for fluorimetric
standards.Individual sample wells and coating standards were measured using a
fluorimeter (Turner Biosystems Modulus 9200). These values were then compared to
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previously obtained fluorescent standards for concentrations to determine coating
concentration values. Average percent grafted, concentration grafted and µg/cm2 was
calculated for each group. Average percent grafted was calculated by subtracting the
average rinse concentration from the average coating concentration. Total concentration
grafted was then calculated using the measured coating concentration multiplied by the
percent grafted to the gel. The concentration grafted was then translated into
micrograms grafted to the gel surface using the coating volume and the molecular
weight of the peptide. This was then multiplied by the surface area of the gel to
determine the average µg/cm2 per group. These values were recorded in Microsoft
Excel 2012 and statistically analyzed by a paired t-test using Minitab 16 statistical
software and α = 0.05.

H.

Quantification of Peptide Coating using Confocal Microscopy

Fluorescently coated gels are imaged using Nikon Eclipse Ti (Nikon Instruments
Inc.; Melville, NY) running the Nikon Elements Image Software (NIS-Elements, AR
3.1.Ink; Laboratory Imaging, Nikon Instruments Inc.; Melville, NY). Images were
taken using a 60x oil immersion objective. The basic confocal setting are as follows:
image capturing speed of 1/8 frames/sec, an image size of 2048x2048 pixels, and a
pinhole size 24.3µm. The initial GFP-UV (for AlexaFluor 488) settings were HV=120,
offset= 0 and laser power = 5% and the Z-steps were set at 1µm with a total area of 20
µm, creating 21 images. Z-stacks were then exported into separate TIF files for each Zstack acquired. Individual images were then combined using ImageJ (Version 1.47) into
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stacks and converted into maximum intensity images to display the total maximum
intensity per sample. All images were then set to a unified scale of 200-2000. The
average intensity of each image was then recorded using the ‘Analyze -> Measure’
feature. These values were recorded in Microsoft Excel 2012 and statistically analyzed
by a paired t-test using Minitab 16 statistical software and α = 0.05.

I.

Preparation of RPEs on Hydrogels

Surface modified PEG-DA hydrogels are seeded with cells at the appropriate
cellular density to achieve confluency for each of the respective cell types and gel
groups (ARPE-19 were approximately 90,000 cells/cm2, PRPE were approximately
110,000 cells/cm2) and were dry seeded by adding cell suspension onto the top of gels
in 12-well plates. After allowing 4 hours for cellular adhesion to the surface of the gel,
the wells were flooded with media to the required volume (500mL). A minimum of
four gels were prepared for each group (0, 5, 10 and 20 µmol/mL) as well as for each
cell type. Gels were then held stationary using size M7 A2 stainless steel washers
(Grainger, Item # 6EY95) and 500 µL of DMEM/F-12 media was added to each gel.
The cells on the gels were fed three times a week. After seven days, the cell-coated gels
were rinsed briefly with PBS and fixed with 4% formaldehyde (16% Formaldehyde
diluted in PBS; Thermo Scientific; Item #28908) for 10 minutes.

38

J.

Preparation of RPEs on Fibronectin

Fibronectin coated coverslips were also used in each study as a positive control.
The control samples were constructed by coating 12mm glass coverslips with
fibronectin (Sigma; Item # F1141) at 1.825 µg/cm2 (100 µl of 21.25 µg/mL per
coverslip). The coated coverslips were then left at 4°C overnight in the refrigerator and
the residual liquid coating was removed before seeding. Cells were then dry seeded at
the appropriate cellular density to achieve confluency for 4 hours and then fed
DMEM/F-12 three times a week. After seven days, the clips were rinsed briefly with
PBS and fixed with 4% formaldehyde (16% Formaldehyde diluted in PBS; Thermo
Scientific; Item #28908) for 10 minutes.

K.

Phase Contrast Microscopy

Fixed gels and coverslip controls were imaged to determine cell confluency using
a phase contrast microscope (Nikon Eclipse TE2000-4) equipped with a Retiga 2000R
Fast Cooled Mono 12 Bit camera (Q Imaging) and interfaced with Metamorph software
(v7.0r2; Universal Imaging Corporation). These images were taken using a 10x air
objective. Light intensity and exposure were adjusted until cell boundaries were easily
visible. Images were then saved as TIF files and cropped to 1200x1200 to remove
objective artifacts shown in the corners of original saved images. Images were also
optimized with the ImageJ software using the ‘Process -> Enhance Contrast’ setting
with saturated pixels set at 0.4% to allow for a more defined boundary layer on each
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image. Next, using the ‘Freehand Selections’ tool, cell edges exposing the underlying
gel were traced and filled in with a solid black color using ‘Edit -> Fill’. After covering
all exposed areas of the gel, a threshold image was generated using ‘Image -> Adjust ->
Threshold’ to convert the image into a binary state. Cells were white while the exposed
gel area was black. The number of white pixels for each image was then obtained using
‘Analyze -> Histogram’ and selecting the ‘List’ button to present numerical values.
This list was then saved and opened in Excel. Using the ratio of white pixels to the total
number of pixels per image, a percentage of total confluency was obtained. The
obtained percentages for each image were then statistically analyzed using a paired ttest using Minitab 16 statistical software and α = 0.05.

L.

Immunostaining Procedure

After 7 days, samples were placed in 12-well plates, permeabilized and blocked
with 0.5% Triton-X (Triton X-100; Item # 082513) in PBS with 1% bovine serum
albumin (BSA, Sigma, Item # A7906-10G) and 0.2% sodium azide (NaN3, Acros
Organics, Item # 190380050) (PBS-BSA-Azide) for 10 minutes, respectively. The
samples were then placed on an orbital rocker throughout the duration of staining. The
samples were then rinsed twice with 300µL of PBS-BSA-Azide for 5 minutes each.
For each gel sample, 250 µL of staining solution was used, except for the fibronectin
control slips where 200 µL of staining solution was used. Following rinsing, the ZO1primary antibody (Rabbit polyclonal Anti-ZO-1; Abcam; ab58720) was added at 1:50
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dilution. The sample was then placed on the rocker at 4°C in the cold room overnight to
allow the primary antibody ample time to bind.
The following day, samples are removed from the rocker, allowed to acclimate to
room temperature and rinsed 6 times with 300 µL of PBS-BSA-Azide for 5 minutes
each. Next, the AlexaFluor 488 labeled secondary antibody (Goat anti-rabbit;
Invitrogen; Item # A11034) was added to each sample at 1:100 dilution in PBS-BSAAzide and rocked for 1 hour at room temperature. Following another 5 rinses with 300
µL of PBS-BSA-Azide for 5 minutes each, rhodamine-phalloidin (R-P; Invitrogen;
R415) in PBS-BSA-Azide at 1:40 dilution was added to the samples and rocked for 40
mins at room temperature. The both gel groups and controls were then rinsed twice
with 300 µL of PBS-BSA-Azide for 5 minutes each. Lastly, the samples are stained
with 4',6-diamidino-2-phenylindole (DAPI; Invitrogen; D1306) at 600nM concentration
in PBS-BSA-Azide for 5 minutes. The samples were then rinsed twice with PBS-BSAAzide and ready for confocal microscopy analysis.

M.

Confocal Microscopy

The immunostained gels and controls were imaged using the same confocal
imaging configuration as mentioned above in section H except the basic confocal
settings were as follows: image capturing speed of 1/24 frames/sec, an image size of
2048x2048 pixels, and a pinhole size from 14.3-32.1. Three imaging channels were
obtained; DAPI, GFP-UV, and TxRed. The initial DAPI settings were HV=84-129,
Offset= 0 and Power = 2-20.1%, while the initial GFP-UV (for AlexaFluor 488)
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settings were HV=75-101, Offset= 0 and Power = 0.5-5.4% and the initial TxRed (for
R-P) settings were HV=70-100, Offset= 0 and Power = 0.1-2.1. Besides image size and
frame speed, each of these parameters were adjusted manually in order to optimize each
recorded image. Z-steps were recorded for each image in order to provide a fully
encompassing image of ZO-1 and actin formations at different heights within the cell.
An average of 20 Z-stack images per final image were acquired for each gel to
encompass the entire thickness of each gel’s cell layer. Z-stacks were then exported
into separate TIF files for all three channels and into separate Z-stacks. Individual
channels were then combined using ImageJ into stacks and converted into maximum
intensity images as well as composite images with all color channels. Due to the
significant amount of time required to image individual gels as well as the requirement
to prepare each gel shortly before imaging to prevent drying, a sample size of n=2 was
used for each set to reduce the effect of photobleaching during preparation and decrease
the effect of time lapse between samples.

N.

ZO-1 Analysis

Staining for ZO-1 was analyzed using ImageJ software. Maximum intensity
images obtained using confocal microscopy were analyzed by first adjusting the image
brightness and contrast using ‘Image -> Adjust -> Brightness/Contrast’ to allow for
easy visualization of ZO-1 boundaries. Cell ZO-1 boundaries were then manually
traced using the ‘Polygon Selections’ tool. Once a cell was traced completely, a line
was drawn onto the image using ‘Edit -> Draw’. This was repeated until no other cells
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could be accurately traced or a sufficient number of samples were obtained to represent
the gel. Samples between n=1 and 21 were obtained for the images collected for this
experiment, depending on the quality of the image and cell size. Once completed, the
file was saved separate from the original ZO-1 image for later use. After the cells were
traced, a binary image was generated using ‘Image -> Adjust -> Threshold’ to convert
the image into a binary state and only display the tracings. This image was then saved
as a separate file and numbered to correlate to measured values. The non-numbered
tracings were then individually selected in numerical order using the ‘Wand’ tool. The
tracings were then measured for area, perimeter, circularity and aspect ratio using
‘Analyze -> Measure’. This was repeated sequentially for each tracing in order and the
measurements were saved to an Excel file. After each image was analyzed, all
measurements were compiled into one single Excel document and average values of
area, perimeter, circularity and aspect ratio were obtained for each group. The compiled
data was also pasted into Minitab 16 and statistically analyzed by a multifactor
ANOVA and a non-paired t-test assuming equal variance using Minitab 16 statistical
software and α = 0.05.

O.

Actin Analysis

Staining for Actin was analyzed using ImageJ software. Maximum intensity
images obtained using confocal microscopy were analyzed by first adjusting the image
brightness and contrast using ‘Image -> Adjust -> Brightness/Contrast’ to allow for
easy visualization of Actin filaments. Actin filaments were then manually traced using

43

the ‘Line’ tool. Once traced, a line was drawn onto the image using ‘Edit -> Draw’.
This was repeated until a sufficient number of samples were obtained to represent the
gel. Once completed, the file was saved separate from the original Actin image for later
use. After the cells were traced, a binary image was generated using ‘Image -> Adjust > Threshold’ to convert the image into a binary state and only display the tracings. This
image was then saved as a separate file and numbered to correlate to measured values.
The non-numbered tracings were then individually selected in numerical order using
the ‘Wand’ tool. The tracings were then measured for length and angle using ‘Analyze > Measure’. This was repeated sequentially for each tracing in order and the
measurements were saved to an Excel file. After each image was analyzed, all
measurements were compiled into one single Excel document and average values of
length and orientation were obtained for each group. The compiled data was also pasted
into Minitab 16 and statistically analyzed by a multifactor ANOVA and a non-paired ttest assuming equal variance using Minitab 16 statistical software and α = 0.05.
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IV.

RESULTS AND DISCUSSION

Four specific aims were addressed in this research. First, the concentration of
PEG-RGDS deposited onto each gel group was evaluated and quantified using a
fluorescently tagged PEG-RGDS substitute. The second specific aim was to evaluate
the ability of PEG-DA hydrogels surface coated with PEG-RGDS to functionally
support attachment of RPE cells. The last two specific aims focused on the observation
of the morphology of both ZO-1 and actin expression by both ARPE-19 and primary
porcine RPE cells. Staining for these specific cellular structures allowed for
quantification of cell circularity, cell area, aspect ratio, actin length and orientation.
Four gel concentration groups (0, 5, 10 and 20 µmol/mL) were used for each study as
well as fibronectin coated 12mm coverslips for a positive control.

A.

Quantification of PEG-RGDS Coating (Fluorescence)

Quantification of the PEG-RGDS coating applied to each group of gels was
analyzed using two different techniques. The first was using retained rinses from
individual gels and obtaining a fluorescent intensity measurement for the amount of
PEG-RGDS-Fluor 488 not polymerized to the surface of the gel. These values were
then compared to a standard generated by using the same volume of each
concentration as the gel coating, exposing it to the same UV time and diluting using
the same amount of rinses. Using the standard curve generated, the average
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concentration per group, percent PEG-RGDS-Fluor 488 grafted and an average
concentration per centimeter squared was obtained. The results of this experiment are
shown in Figures 5 as well as in Tables I-III. Calculations were obtained using the
procedures described in the methods and materials section above.

300000
250000

y = 24092x2 - 35571x
R² = 0.9737

254,116

200000
150000

FSU

84,831

100000
35,490

50000
118
0
0

5

10

-50000

µmol/mL
FIGURE 5- Standard Curve of PEG-RGDS-Fluor 488 Fluorescence

Conc.
µmol /ml
0
5
10
20

Avg. FSU
118
35,490
84,831
254,116

Avg.
µmol/mL
0.026
5.261
9.863
20.009

TABLE I -Standard Curve Analysis
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20

Conc.
µmol/ml
0.026
5.26
9.86
20.01

Avg FSU
169
33,755
81,089
246,532

Avg µmol/mL in
rinse
0.036
4.98
9.37
19.13

%Grafted
-42.94
5.29
5.04
4.40

+/-SD
46.76
6.98
3.90
6.88

µg/cm2
0*
9.09
17.33
30.25

+/-SD
0*
12.00
13.42
47.31

TABLE II - Quantification of PEG-RGDS Coating Fluorescence
*Since percent attachment is less than zero, no PEG-RGDS-Fluor 488 is present.

T-Test p-values
Group
Vs
0
5
0
10
0
20
5
10
5
20
10
20

µg/cm2
p-value
0.113
0.041
0.145
0.143
0.233
0.274

TABLE III -Average µg/cm2 p-values. Yellow indicates significance.

In generating a standard curve, it was noted that the best trend-line fit was a
second order polynomial. Using this generated curve, each individual measurement was
first translated into the values shown in Table I. Table II shows the same values
calculated as percent grafted and micrograms per centimeter squared. Since the
standard curve technique recorded a negative percent attachment for the negative
control gels, the concentration was assumed to be zero and no concentration was
calculated for this group. Total percent attachment for each group was shown to be
between 4 and 5 percent, which is less than the measured yield by Hahn et al. using a
Ninhydrin assay (Hahn et al., 2006) for fluorescently tagged PEG-RGDS for PEG
hydrogels and near identical preparation processes. The increased surface concentration
grafted may also be due to the use of a smaller molecular weight PEG for the hydrogel
itself (3400 vs 6000), increasing free acrylates on the surface and increasing RGDS
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grafting. For the mass per unit area of RGDS coverage results, only the 0 and 10
µmol/mL groups were observed to be significantly different from one another using a
paired t-test, most likely due to the inaccuracies in the analysis technique performed. As
a result, the gel study was further analyzed using confocal microscopy images.

B.

Quantification of PEG-RGDS Coating (Confocal)

After polymerizing gels using the same protocol as the previous quantification
method, each gel was imaged using confocal microscopy to observe the homogeneity of
the coating as well as obtain a greyscale intensity value for comparison of each group.
This was obtained by the creation of a maximum intensity image composed of 21 Zstacks each one-micron apart. The stack begun immediately before fluorescence was
detected and completed when the fluorescent intensity visibly diminished.
Representative images of each group are shown in Figure 6. The average values
obtained from each group are displayed graphically in Figure 7, while the p-values
obtained from a paired t-test is listed in Table IV.
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FIGURE 6- PEG-RGDS-Fluor 488 Hydrogels. Sample images of A) 0 B) 5 C) 10 and D) 20 µmol/mL groups.
Scale bar represents 50µm.
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Avg. Greyscale Intensity

1200
1000

y = 486.58ln(x) + 154.95
R² = 0.9772

751.72

796.02

10

20

800
460.57

600
400
200

157.87

0
0

5

Concentration (µmol/mL)
FIGURE 7- Concentration vs. Average Greyscale Intensity

t-test
Group Vs
0
5
0
10
0
20
5
10
5
20
10
20

Intensity
p-value
0.007
0.011
0.007
0.043
0.048
0.436

TABLE IV -Average Greyscale Intensity p-values. Yellow indicates significance.

The images captured in this study showed highly homogeneous distributions of
the RGDS peptide on the PEG hydrogel via fluorescence, clearly demonstrating that the
PEG-RGDS-Fluor 488 coating is evenly distributed across the surface. All raw images
acquired are shown in Appendix I. The image intensity also decreased as Z-stacks
progressed further into each gel, revealing that the majority of the attached PEGRGDS-Fluor 488 is on the surface of the gel.
Overall, the average intensity measured for each gel group showed significantly
less coefficient of variance than what was shown using the previous technique. This
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method also allowed for statistically significant differences to be shown between each
group except for 10 and 20µmol/mL. The intensity values seemed to plateau near
20µmol/mL, indicating that a maximum concentration may be deposited on the surface
within the polymerization time tested. Interestingly, the R2 value for a linear trend-line
intersecting at the intensity recorded at the 0µmol/mL group is 0.9259, even though the
logarithmic trend shown in the figure displays a higher R2 (0.9772). Larger sample
sizes analyzed for each group may reduce the coefficient of variation further; thereby,
decreasing the coefficient of variation values, improving the linear R2 value and the
level of significance for all groups. In general, this technique proved to be a better tool
for determining quantification of RGDS attached to the surface, since lower variances
were observed between each group as well as providing a visual confirmation that the
RGDS was homogeneously grafted on the surface of the gel.

C.

Quantification of Cellular Confluency on Hydrogels

Cell adhesion was also measured for each sample group in order to determine
whether or not these concentrations allowed significantly different percentages of
attached cells compared to fibronectin coated coverslips. Sample images of cell
adhesion for both ARPE and PRPE cells are shown in Figures 8 and 10 and the
complete set of raw images for all cell adhesion samples can be found in Appendix II.
The results of the analyses performed on all images are shown in Figures 9 and 11 for
ARPE-19 and PRPE cell lines, respectively. P-values for paired t-tests on each cell type
are displayed in Tables V and VI.
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FIGURE 8- ARPE-19 10µmol/mL sample. Scale bar represents 250µm. Black areas indicate bare areas without
cell coverage.

1.200
0.972

0.970

0.976

5

10

20

1.000

Attachment (%)

1.000
0.800
0.600
0.400
0.200
0.012
0.000
0

FN

Coating Concentration (µmol/mL)
FIGURE 9- ARPE-19 Attachment to Surface. Values represent percent cell attachment.
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t-test
Group
0
0
0
0
5
5
5
10
10
20

ARPE
vs
5
10
20
FN
10
20
FN
20
FN
FN

confluency
p-value
<0.0001
<0.0001
<0.0001
<0.0001
0.469
0.437
0.071
0.367
0.038
0.093

TABLE V -ARPE-19 Confluency p-values. Yellow indicates significance.

For the ARPE-19 cells, ≥ 97% confluency was observed for every gel group,
except for the negative controls. A representative image for 10 umol/ml concentration
of RGDS is shown in Figure 11 (all other ARPE-19 confluency images are shown in
Appendix II). All RGDS concentration hydrogel groups were found to be significantly
different than the non-coated gels (0 umol/ml concentration) as expected. Additionally,
the 10µmol/mL group was found to be significantly different than the fibronectin
controls. This may be due to the lack of variance recorded for fibronectin controls since
no images were found to have bare areas without cellular growth.
For PRPE cells, ≥ 97% confluency was observed for every gel group, except for
the negative controls. A representative image for the 10 umol/ml concentration of
RGDS is shown in Figure 13 (all other PRPE confluency images are shown in
Appendix II). Only the non-coated gels were statistically significant from all other gels
as was expected.
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FIGURE 10- PRPE 10µmol/mL sample. Scale bar represents 250µm. Black areas indicate bare areas without
cell coverage.

1.200

Confluency (%)

1.000

0.994
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0.999
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FIGURE 11- PRPE Attachment to Surface. Values represent percent cell attachment.
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t-test
Group
0
0
0
0
5
5
5
10
10
20

P
vs
5
10
20
FN
10
20
FN
20
FN
FN

confluency
p-value
<0.0001
<0.0001
<0.0001
<0.0001
0.125
0.078
0.102
0.087
0.075
0.173

TABLE VI -PRPE Confluency p-values. Yellow indicates significance.

As for both cell types, nearly all groups measured showed no significant
differences when compared to fibronectin controls. This shows that all concentrations
are capable of promoting a confluent layer of cells for both cell types. These results
also match well with observed PEG-RGDS surface densities (0-100 µg/cm2) for human
dermal fibroblasts (Moon 2009). Perfecting the gel fabrication procedures to attain
smoother gel surfaces may increase the observed cell confluency since a small portion
of confluency defects appeared to be due to imperfections in the gel surface. The
imperfections may have been a result of bubble formation during the coating procedure
since RPE cells tend to prefer a flat surface in order to fully propagate (Scherzer 2010).
As for achieving an optimal concentration of PEG-RGDS for RPE cell adhesion and
allowing cells to migrate onto the surface, one would need to select a concentration
requiring the lowest amount of PEG-RGDS while still supporting appropriate cell
morphology and differentiation in order to decrease overall production costs.
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D.

Determination of RPE Differentiation: ZO-1 Cell Circularity

RPE cellular morphology was also observed using immunocytochemistry
techniques. All groups were coated with cells at confluent densities and fixed after 7
days. A sample size of two per group was used for staining each time the experiment
was executed due to the large amount of time required to image each sample. All
sample images were then analyzed using ImageJ and Minitab 16. A representative
image for 10 umol/ml concentration of RGDS is shown in Figure 12 (all other ZO-1
images are shown in Appendix III). Analyzed gels are also located in Appendix III and
are labeled as ‘ZO-1 analysis’. The total number of cells measured as well as number of
gels analyzed are listed in Table VII. Only one image in the 0µmol/mL gels was found
to have an attached cell layer; however, based on the fact that this layer of cells was not
adhered to the substrate, was folded over on itself and did not demonstrate confluency,
this image was not included in the analysis.

FIGURE 12- PRPE 10-2-1 (5/17/13)
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Sample Gel # Counted
ARPE-5
1
8
ARPE-10
1
5
2
12
ARPE-20
1
5
2
16
ARPE-FN
1
3
2
1
3
3
PRPE-5
1
13
2
7
3
11
PRPE-10
1
13
2
11
3
9
4
11
PRPE-20
1
11
3
5
4
9
PRPE-FN
1
11
2
13
3
15
4
21
TABLE VII -Gel and Cell Number Count

Cellular circularity is determined using Equation 1. This equation provides a
value between zero and one, with one being a perfect circle. As a cell becomes more
densely packed and more epithelioid in shape, the circularity value of the cellular
boundary approaches one. Therefore, the higher the circularity value the more
epithelioid and differentiated the cell.

𝑓𝑐𝑖𝑟𝑐 =

4𝜋 ∙ 𝐴𝑟𝑒𝑎
𝑃𝑒𝑟𝑖𝑚𝑒𝑡𝑒𝑟 2
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𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1

Due to the inability to discern proper ZO-1 expression in some images, only a few
cells were analyzed from each gel, especially in the ARPE-19 images. A minimum of
four gels were analyzed for all samples, but only images containing ZO-1 expression
for analysis are included within the numerical values and figures. Figure 13 also shows
an example of the differences between images, where the left image illustrates cells in a
more epithelioid shape, which corresponds to higher circularity values. The image on
the right demonstrates cells that display more fibroblastic phenotypic behavior, with
smaller circularity values and significantly less ZO-1 expression around the perimeter
of the cells.

FIGURE 13- Left – PRPE cells on fibronectin, image FN-2-2; and, Right - ARPE cells on fibronectin, image FN1-4. The bright oval/circular spots indicate nuclei and the bright lines surrounding the nuclei identify ZO-1
located on the periphery of the cells.

The following data on cell circularity was obtained from the analysis of the ZO-1
images obtained from each group (Figure 14). Only one RGDS concentration pair was
found to be statistically significant for ARPE-19 cells (10 and 20µmol/mL), although
the RGDS concentration pair of 10µmol/mL and FN show a p-value of 0.08. For the
58

PRPEs, all RGDS concentration pairs were found to be statistically significant from the
fibronectin controls. This shows that fibronectin promotes a more epithelioid shape
than all three RGDS gel concentrations. In comparing differences between cell types at
the same RGDS gel concentrations, t-test analysis showed a significant difference for
all cases, except for the 10µmol/mL, with PRPE cells displaying a higher circularity
(Table VIII). This is potentially due to a smaller sample size within ARPE-19 samples
(17), increasing the potential variability of the sample and decreasing its significance
compared to the number of PRPE samples (44).
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0.800

0.701
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0.700
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0.600
0.500
0.400
0.300
0.200
0.100
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FIGURE 14- Circularity by Group. Bars indicate standard deviation.

t-test
Group
5
5
5
10
10
20

A Circularity
vs
p-value
10
0.176
20
0.187
FN
0.270
20
0.011
FN
0.080
FN
0.495

t-test
Group
5
5
5
10
10
20

P Circularity
vs
p-value
10
0.132
20
0.311
FN
0.000
20
0.288
FN
0.000
FN
0.000

t-test
Circularity
Group vs
p-value
A-5
P-5
0.022
A-10 P-10
0.237
A-20 P-20
0.000
A-FN P-FN
0.038

TABLE VIII -Circularity p-values Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE
groups. Yellow indicates significance.
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A multi-factor ANOVA following the General Linear Model was also performed
using Minitab 16 to observe significance between concentrations, gels and cell types.
Three ANOVAs were performed; one ANOVA for each cell type as well as an
ANOVA for all samples. These results are listed in Table IX. Individual PRPE gels are
shown to be a significant factor in the ANOVA as well as between the different RGDS
gels concentrations. Cell type, concentration and RGDS gel concentration are also
shown to be significantly different when comparing the ANOVA data between cell
types. A Tukey’s Test analysis to determine circularity differences between gels of
different RGDS concentrations is shown in Table X, with the PRPE data showing a
statistically significant difference between fibronectin and the rest of the RGDS
concentrations, matching the p-values in Table VIII.

ARPE
Factor
Concentration
Gel(Conc)
R-Sq(Adj)

Circularity
p-value
0.069
0.317
0.0833

PRPE
Circularity
Factor
p-value
Concentration
0.000
Gel(Conc)
0.007
R-Sq(Adj)
0.3769

ARPE/PRPE
Circularity
Factor
p-value
Type
0.002
Concentration
0.000
Gel(Conc)
0.027
R-Sq(Adj)
0.2916

TABLE IX -ANOVA for Circularity. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE
groups. Yellow indicates significance.

ARPE Group
5
A
10
A
20
A
FN
A

PRPE Group
5
B
10
B
20
B
FN
A

TABLE X -Tukey’s Test for Circularity vs. Concentration. Letters indicate groups significant from one another.

In general, the circularity values recorded for ARPE-19 cells show no significance
between groups. PRPE groups for circularity also show significantly smaller values
than fibronectin. This shows that RGDS does not significantly promote higher
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circularity values than fibronectin itself. Further evaluation should help indicate if this
trend of conveying dedifferentiation is also indicated through the rest of the parameters
measured below.

E.

Determination of RPE Differentiation: ZO-1 Cell Perimeter

Analysis of ZO-1 images also included obtaining cell perimeter values. The
following data on cell perimeter was obtained from the analysis of ZO-1 images
obtained from each group (Figure 15).
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FIGURE 15- Perimeter by Group. Bars indicate standard deviation.

t-test ARPE Perim
Group
vs
p-value
5
10
0.214
5
20
0.061
5
FN
0.417
10
20
0.266
10
FN
0.286
20
FN
0.108

t-test PRPE Perim
Group
vs
p-value
5
10
0.001
5
20
0.065
5
FN
0.000
10
20
0.000
10
FN
0.124
20
FN
0.000

t-test
Perim
Group vs p-value
A-5
P-5
0.330
A-10 P-10 0.012
A-20 P-20 0.013
A-FN P-FN 0.001

TABLE XI -Perimeter p-values Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE groups.
Yellow indicates significance.
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Of the data collected for ARPE-19 cells, no statistically significant difference was
found between any of the samples, although the difference between 5 and 20µmol/mL
is less than 0.07 (Table XI). This indicates that with increased statistical samples, the
variability between these two groups may become significant. This observation may
also be an indication that since ARPE-19s are an immortalized cell line, they may
respond significantly different to substrate integrin concentrations. Although no
statistically significant differences were found between ARPE-19 groups, the same
cannot be said for PRPEs seeded on gels with different RGDS concentrations. All
RGDS gel concentrations but 10mol/mL show significant differences from the
fibronectin controls as well as a significant difference between 10 and 20µmol/mL and
between 5 and 10µmol/mL. Interestingly, no significant difference is noted between
these two paired groups for PRPE when measured for circularity. This may indicate
that an increase in perimeter does not necessarily coincide or directly correlate with a
fibroblastic morphology. This is shown in the reorganization of RPEs in vivo when
cells begin to die with age. RPEs will tend to spread circumferentially to fill in small
defects instead of becoming polarized (Grierson et al. 1994).
A multi-factor ANOVA following the General Linear Model was also performed
using Minitab 16 to observe significant differences between concentrations, gels and
cell types. Three ANOVAs were performed; one ANOVA for each cell type as well as
an ANOVA for all samples. These results are listed in Tables XII. Tukey’s Test for
perimeter is also shown in Table XIII.
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ARPE
Perimeter
Factor
p-value
Concentration
0.269
Gel(Conc)
0.090
R-Sq(Adj)
0.0837

PRPE
Perimeter
Factor
p-value
Concentration
0.000
Gel(Conc)
0.099
R-Sq(Adj)
0.2111

ARPE/PRPE
Perimeter
Factor
p-value
Type
0.005
Concentration
0.000
Gel(Conc)
0.163
R-Sq(Adj)
0.1596

TABLE XII -ANOVA for Perimeter. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE
groups. Yellow indicates significance.

ARPE Group
5
A
10
A
20
A
FN
A

PRPE Group
5
A
10
B
20
A
FN
B

TABLE XIII -Tukey’s Test for Perimeter vs. Concentration. Letters indicate groups significant from one
another.

The ANOVA in Table XII also shows similar results as the t-tests above. PRPE
concentration is shown to be significant factor in the ANOVA. Type and concentration
are also shown to be significant with the ANOVA data including both cell types.
Tukey’s Test with PRPEs shows that there are two significantly different groups, 5 and
20µmol/mL as compared to 10µmol/mL and fibronectin, matching the significance
shown between groups in Table XI.
In general, perimeter values recorded for ARPE-19 cells also show minimal
variation between groups with no specific trend with increasing RGDS concentration.
PRPE groups also show similar data. This indicates that RGDS does not significantly
promote a differentiated state related to a smaller perimeter. Again, further evaluation
of the last two parameters should help convey if this trend of parameters demonstrating
a dedifferentiated, fibroblastic morphology.
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F.

Determination of RPE Differentiation: ZO-1 Cell Area

ZO-1 images were also measured for cellular area. The following data on cell area
was obtained from the analysis of ZO-1 images for each group (Figure 16).
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500.00
400.00
300.00
200.00
100.00
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ARPE-5 ARPE-10 ARPE-20 ARPE-FN PRPE-5

PRPE-10 PRPE-20 PRPE-FN

FIGURE 16- Area by Group. Bars indicate standard deviation.

t-test ARPE Area
Group
vs
p-value
5
10
0.120
5
20
0.059
5
FN
0.282
10
20
0.393
10
FN
0.267
20
FN
0.176

t-test PRPE Area
Group
vs
p-value
5
10
0.002
5
20
0.017
5
FN
0.005
10
20
0.000
10
FN
0.432
20
FN
0.000

t-test
Area
Group vs p-value
A-5
P-5
0.070
A-10 P-10 0.003
A-20 P-20 0.030
A-FN P-FN 0.001

TABLE XIV -Area p-values. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE groups.
Yellow indicates significance.

No statistical significance was observed for cell area in ARPE-19 cells, although
groups 5 and 20µmol/mL was shown to be less than 0.06 (Table XIV). Increased cell
sample measurements may potentially reduce this p-value, indicating significance
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between these groups. For PRPE cells, 5 and 20 µmol/mL were found to be statistically
different from fibronectin controls, whereas 10 umol/ml was not. Differences between
each of the RGDS gel concentrations were also shown to be statistically significantly
different. These findings further indicate that increasing RGDS concentrations does not
significantly impact morphology. An increase in area is also typically associated with,
in vivo, death and rearrangement of the RPEs (Grierson et al., 1994). Since these cells
do not proliferate for small defects, their area increases to compensate for the reduction
in cell density, which may correlate to the higher area values recorded for both cell
types.
A multi-factor ANOVA following the General Linear Model was also performed
using Minitab 16 to observe significance between concentrations, gels and cell types.
Three ANOVAs were performed; one ANOVA for each cell type as well as an
ANOVA for all samples. These results are listed in Tables XV. Tukey’s Test for area is
also shown in Table XVI.

ARPE
Area
Factor
p-value
Concentration 0.368
Gel(Conc)
0.108
R-Sq(Adj)
0.0755

PRPE
Area
Factor
p-value
Concentration 0.000
Gel(Conc)
0.053
R-Sq(Adj)
0.1793

ARPE/PRPE
Area
Factor
p-value
Type
0.000
Concentration 0.003
Gel(Conc)
0.098
R-Sq(Adj)
0.1473

TABLE XV -ANOVA for Area. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE groups.
Yellow indicates significance.

ARPE Group
5
A
10
A
20
A
FN
A

PRPE Group
5
A
10
B
20
A
FN
B

TABLE XVI -Tukey’s Test for Area vs. Concentration. Letters indicate groups significant from one another.
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The ANOVA in Table XV again shows comparable data as the t-tests above.
PRPE concentration is shown to be a significant factor in the ANOVA, revealing
statistically significant values recorded for RGDS concentration. Cell type and cell
concentration were also significantly different for the ANOVA. Tukey’s Test with
PRPEs shows that there are two significantly different groups, 5 and 20µmol/mL as
compared to 10µmol/mL and fibronectin, similar to the significance shown between
groups in Table XIV, although the t-tests indicate that 5 and 20µmol/mL are
significantly different. This is due to differences in calculation of significance, but also
shows that other factors may decrease the significance between groups, such as
recorded individual gel variation.
In general, area values recorded for ARPE-19 cells also show minimal variation
between groups with no specific trend. PRPE groups show significance from other
concentrations and controls, but no clear trend due to increasing concentration,
revealing there may be other potential influences. This indicates that RGDS does not
directly promote a differentiated state related to a smaller area, although further
evaluation of the last parameter should help convey if the values previously shown truly
display a dedifferentiated, fibroblastic morphology.

G.

Determination of RPE Differentiation: ZO-1 Aspect Ratio

Finally, ZO-1 images were also measured for cellular aspect ratio. The following
data on cell aspect ratio was obtained from the analysis of ZO-1 images obtained from
each group (Figure 17).
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FIGURE 17- Aspect Ratio by Group Bars indicate standard deviation.

t-test ARPE Aspect
Group vs
p-value
5
10
0.377
5
20
0.133
5
FN
0.362
10
20
0.160
10
FN
0.438
20
FN
0.283

t-test PRPE Aspect
Group vs
p-value
5
10
0.078
5
20
0.003
5
FN
0.365
10
20
0.022
10
FN
0.033
20
FN
0.000

t-test
Group
A-5
A-10
A-20
A-FN

Aspect
vs
p-value
P-5
0.021
P-10
0.163
P-20
0.045
P-FN
0.022

TABLE XVII-Aspect Ratio p-values. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE
groups. Yellow indicates significance.

Again, no significant difference was found between any groups in ARPE-19 cells
(Table VII). For PRPE, fibronectin controls were significantly different than the 10 and
20 µmol/mL RGDS concentration groups, but not the 5 µmol/mL group. This shows
that fibronectin controls promote the smallest aspect ratio, demonstrating a higher
cellular surface density and potentially more differentiated state. The 20 µmol/mL
group was also found to be significantly different than all other groups. This further
indicates that other factors may be effecting morphology, since no proportional
relationship is shown by increasing concentrations of RGDS.
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Another interesting finding is the relationship of the 5 µmol/mL PRPE circularity
and aspect ratio. This group has the second lowest average circularity value and has the
second lowest aspect ratio. For a perfect circle or shapes nearing a circular shape, a
high circularity value as well as a low aspect ratio are recorded. This must mean that for
this group cells are forming shapes other than the typical epithelioid-hexagon, such as a
squared or triangular form. In contrast, PRPE fibronectin controls show an inverse
relationship between aspect ratio (low) to circularity (high). This reveals the fibronectin
controls are potentially promoting a more differentiated state.
A multi-factor ANOVA following the General Linear Model was also performed
using Minitab 16 to observe significance between concentrations, gels and cell types.
Three ANOVAs were performed; one ANOVA for each cell type as well as an
ANOVA for all samples. These results are listed in Tables XVIII. Tukey’s Test for
aspect ratio is also shown in Table XIX.

ARPE
Factor
Concentration
Gel(Conc)
R-Sq(Adj)

Aspect
Ratio
p-value
0.526
0.117
0.0397

PRPE
Factor
Concentration
Gel(Conc)
R-Sq(Adj)

Aspect
Ratio
p-value
0.000
0.042
0.1425

Aspect
ARPE/PRPE
Ratio
Factor
p-value
Type
0.024
Concentration 0.005
Gel(Conc)
0.004
R-Sq(Adj)
0.1283

Table XVIII -ANOVA for Aspect Ratio. Left- ARPE-19 groups. Center- PRPE groups. Right- ARPE vs. PRPE
groups. Yellow indicates significance.

ARPE Group
5
A
10
A
20
A
FN
A

PRPE Group
5
BC
10
AB
20
A
FN
C

Table XIX Tukey’s Test for Aspect Ratio vs. Concentration. Letters indicate groups significant from one
another.
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The ANOVA in Table XVIII also shows similar results as the t-tests above. PRPE
concentration is shown to be a significant factor in the ANOVA as well as the gel
concentrations. Cell type, concentration and gel concentrations were also shown to be
significantly different. The Tukey’s Test for the PRPEs shows that there are three
significantly different groups, 10 and 20µmol/mL, 5 and 10µmol/mL and 5µmol/mL
and fibronectin, , similar to the significance shown between groups in Table XVII.
Although the data shows three significantly different groups, no correlation to
increasing RGDS concentration is shown, indicating that these significances may be
caused by other factors.
Although ZO-1 measurements provide a quantifiable method for determining
cellular differentiation and morphology based on visual parameters, the values obtained
for both cell types indicate that the concentrations used for this study were insufficient
in promoting epithelioid differentiation similar to fibronectin controls. This may
potentially suggest that RGDS may be insufficient in itself to promote the desired
morphology of these cells, requiring a combination of other peptides along with RGDS
or the use of another adhesion ligand based peptide alone. Future research could
potentially include the use of other fibronectin-based peptide sequences shown to
enhance the use of RGDS, such as PHSRN (Feng et al., 2004). Other adhesive ligand
based peptides may also be of interest, such as sequences based on collagen IV.
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H.

Determination of RPE Differentiation: Actin Filament Length and Orientation

Actin filament distribution was also observed using immunocytochemistry
techniques. Samples were stained for rhodamine-phalloidin along with ZO-1 staining
as mentioned above. Samples were then analyzed using confocal microscopy and
imageJ software to observe the morphological characteristics of F-actin. This
experiment was then repeated in order to obtain a sample size large enough to
statistically analyze using Minitab 16. All Actin filament images are shown in
Appendix III.
In typical RPE morphology, actin filaments are strongly associated with tight
junction formation around the perimeter of the cells. As shown in Figure 22, typical
actin expression is predominantly found in the same area as ZO-1 and other tight
junction related proteins. As RPE cells become more dedifferentiated, the cells become
more fibroblastic and express actin stress fibers as well as α-smooth muscle actin
(Grierson et al., 1994).
When analyzing actin for each group, large amounts of actin were found
throughout the volume of the cell. This strongly indicates that stress-related fibers have
been produced either due to substrate, soluble or spatially initiated cues. This also
indicates the promotion of dedifferentiation into fibroblastic morphologies. These
observations also correlate with the aberrant circularity and aspect ratio values obtained
through ZO-1 measurements. The promotion of large amounts of intracellular actin also
made the ability to distinguish circumferential actin extremely difficult, preventing
accurate measurement of circumferential actin length and angle orientation to correlate
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with ZO-1 circularity and aspect ratio values. Sample images are shown in Figure 18
with the left image being PRPE cells on fibronectin. On the top 1/3 of the image,
appropriate actin morphology is shown, but only for a few cells. In the same image
towards the lower half, an increase in actin is expressed, making cellular boundaries
indistinguishable. The right image shows ARPE-19 cells on fibronectin; however, the
cell boundaries are indistinguishable in the entire image, making actin length and
orientation measurements based on individual cell shape unobtainable.
Figure 19 demonstrates an appropriate actin morphology when RPE cells are
adequately differentiated (Lee 2007). Using this morphology, actin length and
orientation can be determined and shown to correlate with ZO-1 circularity and aspect
ratio values. Actin lengths should be roughly equal on all sides and have a near
horizontal distribution of angles between 0 and 180 degrees when cells are adequately
differentiated. Any increase in the average length or change in variation from a normal
angle distribution would indicate a shift toward a fibroblastic morphology due to the
increasing polarity of the cells. A significant increase in intracellular actin expression
would suggest a shift to a dedifferentiated state for the cell, as illustrated in the images
obtained in this study.
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FIGURE 18- Actin Expression on Fibronectin controls. Left- PRPE FN 2-2 Right- ARPE FN 1-4

FIGURE 19- Actin Expression in Differentiated RPEs (acquired from Lee 2007)
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V.

CONCLUSIONS

Four specific aims were analyzed for the duration of this research. First, the
technique for surface modification of PEG hydrogels with PEG-RGDS adhesion
ligand was quantified using AlexaFluor 488 conjugated PEG-RGDS. This study found
that between four and five percent of the total PEG-RGDS solution was polymerized
on the surface for each gel group. This showed the functionality of the technique as
well as providing a range of adhesion ligand concentration to correlate with cell
confluency values for a later specific aim. Further analysis of the fluorescently coated
gels using confocal microscopy also proved statistical significance between all coating
concentrations except for 10 and 20 µmol/mL. It was also shown that the peptide layer
is homogeneous throughout the surface of each gel.
For the second specific aim, cellular confluency was compared on differing
concentrations of adhesion ligands on PEG hydrogels and compared to non-coated
PEG gels and fibronectin coated coverslips. Of the two cell types, only one group was
found to be statistically significant from the fibronectin control; the 10 µmol/mL
ARPE-19 group. This statistical significance could be caused by the lack of bare gel
observed in the fibronectin controls, but should still be considered when trying to
optimize the concentration of adhesion ligand for this cell type. All groups of both
cell types were also found to be statistically significant from the negative control gels.
This shows that in terms of cellular adhesion, the entire range of concentrations could
potentially be used for both cell types.
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In terms of differentiated RPE morphology, experimental data showed different
results compared to confluency in terms of appropriate concentration of adhesion
peptide. In general for ZO-1 studies, low sample sizes in 5µmol/mL and fibronectin
controls in the ARPE-19 studies only seemed to affect results by reducing the variation
seen between gels, preventing a visible significant difference between groups. All four
parameters also showed statistical significance between cell types, indicating that both
of these cell types do not respond identically to one another.
Images taken for R-P were unable to be appropriately analyzed for
circumferential actin length and angle compared to ZO-1 due to significant amounts of
intracellular actin expression typically only expressed by fibroblastic type RPEs. This
shows that both cell types in all groups were expressing some indicators for
fibroblastic dedifferentiation.
In conclusion, although the studied levels of PEG-RGDS allowed for near
confluent levels of RPE cells on PEG hydrogels, cellular circularity, area, perimeter
and aspect ratio did not seem to be related in any proportion to RGDS surface
concentration. Fibronectin controls in all cases indicated the closest epithelial
morphology based on ZO-1 expression. Other conditions may be potential factors that
allow RPEs to become dedifferentiated, such as spatial distribution, material stiffness
or lack of certain factors that promote differentiation. In conclusion, the hypothesis
that increasing concentrations of PEG-RGDS on PEG-DA hydrogels will significantly
promote morphological expression tied to RPE-specific differentiation in both ARPE19 and primary PRPE cell lines was found to be false based on the results of this
research.
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VI.

RECOMMENDATIONS

Additional work will be needed in order to fully characterize the state of
differentiation for RPE cells seeded on PEG-RGDS coated hydrogels. Factors such as
RPE 65 and cellular retinaldehyde binding protein can be stained using similar
immunocytochemistry techniques to obtain differentiation information, since these
factors are only produced when these cells are in a differentiated state.
In general, more research must be conducted in the promotion and sustainment of
RPE cells of differentiated epithelial states after achieving confluency. Fibronectin and
fibronectin-based layers have shown to promote excellent migratory and proliferative
responses but do not seem to promote differentiation after achieving confluency based
on the experimental results discussed above. Alteration of post-confluent media with
compounds that promote differentiation may also prove to be beneficial if the end goal
is to transplant a fully functioning sheet of cells on the hydrogel into the damaged area.
As for using the currently developed material in the wound site to encourage migration
and proliferation by existing RPEs, other factors may be required in order to promote a
differentiated state after confluency is reached. These factors could be either substrate
based, such as collagen or heparin sulfate or based on growth factors that are released
after reaching confluency. Other peptides based on other functional domains of
integrins could also be included to promote a differentiated state. Other peptide
sequences from non-fibronectin based extracellular matrix proteins could also be used
such as sequences from collagen IV. Animal studies using PEG-RGDS coated
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hydrogels should also be performed to evaluate the efficiency of proliferation and
differentiation in vivo, since potential differentiation factors may be present in the body
after confluency is reached and a semi-functioning RPE layer is established. In terms of
encouraging differentiation, growth factor ‘pockets’ that release upon cell contact or
PEG acrylate modified growth factors that promote RPE differentiation could be
included within the gel. Further work must then be conducted to ensure adequate repair
of the adjacent neuronal layer as well as the choricocapillaris in order to restore all
tissue layers to their normal, functioning state.
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APPENDIX I: Gel Concentration Quantification Images

All images follow the same naming format:
Gel-(Concentration)-(Gel Number)-(Image Number)
All quantification images are taken at 60x.
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FIGURE A1.1- Gel 0-1-1

FIGURE A1.2- Gel 0-2-1
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FIGURE A1.3- Gel 0-3-1

FIGURE A1.4- Gel 0-4-1
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FIGURE A1.5- Gel 5-1-1

FIGURE A1.6- Gel 5-2-1

85

FIGURE A1.7- Gel 5-3-1

FIGURE A1.8- Gel 5-4-1
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FIGURE A1.9- Gel 10-1-1

FIGURE A1.10- Gel 10-2-1
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FIGURE A1.11- Gel 10-3-1

FIGURE A1.12- Gel 10-4-1
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FIGURE A1.13- Gel 20-1-1

FIGURE A1.14- Gel 20-2-1
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FIGURE A1.15- Gel 20-3-1

FIGURE A1.16- Gel 20-4-1

90

APPENDIX II: Gel Confluency Images

All images follow the same naming format:
(Cell Type) (Concentration)-(Gel Number)-(Image Number)
All quantification images are taken at 60x.
Solid black images represent complete (100%) cellular coverage.
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FIGURE A2.1- ARPE 0-1-1 Confluency
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FIGURE A2.2- ARPE 0-1-2 Confluency
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FIGURE A2.3- ARPE 0-1-3 Confluency
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FIGURE A2.4- ARPE 0-2-1 Confluency
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FIGURE A2.5- ARPE 0-2-2 Confluency

96

FIGURE A2.6- ARPE 0-2-3 Confluency
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FIGURE A2.7- ARPE 0-3-1 Confluency
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FIGURE A2.8- ARPE 0-3-2 Confluency
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FIGURE A2.9- ARPE 0-3-3 Confluency
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FIGURE A2.10- ARPE 5-1-1 Confluency
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FIGURE A2.11- ARPE 5-1-2 Confluency
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FIGURE A2.12- ARPE 5-1-3 Confluency
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FIGURE A2.13- ARPE 5-2-1 Confluency
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FIGURE A2.14- ARPE 5-2-2 Confluency
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FIGURE A2.15- ARPE 5-2-3 Confluency
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FIGURE A2.16- ARPE 5-3-1 Confluency
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FIGURE A2.17- ARPE 5-3-2 Confluency
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FIGURE A2.18- ARPE 5-3-3 Confluency
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FIGURE A2.19- ARPE 10-1-1 Confluency
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FIGURE A2.20- ARPE 10-1-2 Confluency
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FIGURE A2.21- ARPE 10-1-3 Confluency
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FIGURE A2.22- ARPE 10-2-1 Confluency
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FIGURE A2.23- ARPE 10-2-2 Confluency
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FIGURE A2.24- ARPE 10-2-3 Confluency
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FIGURE A2.25- ARPE 10-3-1 Confluency
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FIGURE A2.26- ARPE 10-3-2 Confluency
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FIGURE A2.27- ARPE 10-3-3 Confluency
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FIGURE A2.28- ARPE 20-1-1 Confluency
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FIGURE A2.29- ARPE 20-1-2 Confluency
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FIGURE A2.30- ARPE 20-1-3 Confluency
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FIGURE A2.31- ARPE 20-2-1 Confluency
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FIGURE A2.32- ARPE 20-2-2 Confluency
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FIGURE A2.33- ARPE 20-2-3 Confluency
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FIGURE A2.34- ARPE 20-3-1 Confluency
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FIGURE A2.35- ARPE 20-3-2 Confluency
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FIGURE A2.36- ARPE 20-3-3 Confluency
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FIGURE A2.37- ARPE FN-1-1 Confluency
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FIGURE A2.38- ARPE FN-1-2 Confluency
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FIGURE A2.39- ARPE FN-1-3 Confluency
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FIGURE A2.40- ARPE FN-2-1 Confluency
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FIGURE A2.41- ARPE FN-2-2 Confluency
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FIGURE A2.42- ARPE FN-2-3 Confluency

133

FIGURE A2.43- ARPE FN-3-1 Confluency
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FIGURE A2.44- ARPE FN-3-2 Confluency
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FIGURE A2.45- ARPE FN-3-3 Confluency
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FIGURE A2.46- PRPE 0-1-1 Confluency

137

FIGURE A2.47- PRPE 0-1-2 Confluency

138

FIGURE A2.48- PRPE 0-1-3 Confluency
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FIGURE A2.49- PRPE 0-2-1 Confluency
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FIGURE A2.50- PRPE 0-2-2 Confluency
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FIGURE A2.51- PRPE 0-2-3 Confluency
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FIGURE A2.52- PRPE 0-3-1 Confluency

143

FIGURE A2.53- PRPE 0-3-2 Confluency

144

FIGURE A2.54- PRPE 0-3-3 Confluency
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FIGURE A2.55- PRPE 5-1-1 Confluency

146

FIGURE A2.56- PRPE 5-1-2 Confluency

147

FIGURE A2.57- PRPE 5-1-3 Confluency

148

FIGURE A2.58- PRPE 5-2-1 Confluency
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FIGURE A2.59- PRPE 5-2-2 Confluency
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FIGURE A2.60- PRPE 5-2-3 Confluency
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FIGURE A2.61- PRPE 5-3-1 Confluency
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FIGURE A2.62- PRPE 5-3-2 Confluency
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FIGURE A2.63- PRPE 5-3-3 Confluency
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FIGURE A2.64- PRPE 10-1-1 Confluency
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FIGURE A2.65- PRPE 10-1-2 Confluency
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FIGURE A2.66- PRPE 10-1-3 Confluency

157

FIGURE A2.67- PRPE 10-2-1 Confluency
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FIGURE A2.68- PRPE 10-2-2 Confluency

159

FIGURE A2.69- PRPE 10-2-3 Confluency
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FIGURE A2.70- PRPE 10-3-1 Confluency
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FIGURE A2.71- PRPE 10-3-2 Confluency
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FIGURE A2.72- PRPE 10-3-3 Confluency
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FIGURE A2.73- PRPE 20-1-1 Confluency
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FIGURE A2.74- PRPE 20-1-2 Confluency

165

FIGURE A2.75- PRPE 20-1-3 Confluency

166

FIGURE A2.76- PRPE 20-2-1 Confluency

167

FIGURE A2.77- PRPE 20-2-2 Confluency

168

FIGURE A2.78- PRPE 20-2-3 Confluency

169

FIGURE A2.79- PRPE 20-3-1 Confluency
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FIGURE A2.80- PRPE 20-3-2 Confluency

171

FIGURE A2.81- PRPE 20-3-3 Confluency
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FIGURE A2.82- PRPE FN-1-1 Confluency
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FIGURE A2.83- PRPE FN-1-2 Confluency
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FIGURE A2.84- PRPE FN-1-3 Confluency

175

FIGURE A2.85- PRPE FN-2-1 Confluency

176

FIGURE A2.86- PRPE FN-2-2 Confluency

177

FIGURE A2.87- PRPE FN-2-3 Confluency

178

FIGURE A2.88- PRPE FN-3-1 Confluency
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FIGURE A2.89- PRPE FN-3-2 Confluency
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FIGURE A2.90- PRPE FN-3-3 Confluency
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APPENDIX III: Confocal Microscopy Images

All images follow the same naming format:
(Cell Type) -(Concentration)-(Gel Number)-(Image Number) (Date Taken)
All images are taken at 60x.
Top left: Composite image
Top right: Actin Staining
Bottom Left: DAPI staining
Bottom Right: ZO-1 staining
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FIGURE A3.1- ARPE 0-1-1 (5/10/13)
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FIGURE A3.2- ARPE 0-2-1 (5/10/13)
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FIGURE A3.3- ARPE 0-3-1 (6/7/13)
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FIGURE A3.4- ARPE 0-4-1 (6/7/13)
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FIGURE A3.5- ARPE 5-1-1 (5/10/13)
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FIGURE A3.6- ARPE 5-1-1 ZO-1 Analysis
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FIGURE A3.7- ARPE 10-1-1 (5/10/13)

189

FIGURE A3.8- ARPE 10-1-1 ZO-1 Analysis
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FIGURE A3.9- ARPE 10-2-1 (5/10/13)
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FIGURE A3.10- ARPE 10-2-1 ZO-1 Analysis

192

FIGURE A3.11- ARPE 20-1-3 (5/10/13)
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FIGURE A3.12- ARPE 20-1-3 ZO-1 Analysis
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FIGURE A3.13- ARPE 20-2-1 (5/10/13)
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FIGURE A3.14-ARPE 20-2-1 ZO-1 Analysis
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FIGURE A3.15- ARPE FN-1-4 (6/7/13)
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FIGURE A3.16- ARPE FN-1-4 ZO-1 Analysis
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FIGURE A3.17- ARPE FN-3-1 (6/7/13)
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FIGURE A3.18- ARPE FN-3-1 ZO-1 Analysis
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FIGURE A3.19- ARPE FN-4-1 (6/7/13)
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FIGURE A3.20- ARPE FN-4-1 ZO-1 Analysis
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FIGURE A3.21- PRPE 0-1-1 (5/17/13)
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FIGURE A3.22- PRPE 0-2-1 (5/17/13)
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FIGURE A3.23- PRPE 0-3-1 (6/1/13)
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FIGURE A3.24- PRPE 0-4-1 (6/1/13)
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FIGURE A3.25- PRPE 5-1-1 (5/17/13)

207

FIGURE A3.26- PRPE 5-1-1 ZO-1 Analysis

208

FIGURE A3.27- PRPE 5-2-1 (5/17/13)
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FIGURE A3.28- PRPE 5-2-1 ZO-1 Analysis

210

FIGURE A3.29- PRPE 5-3-1 (6/1/13)

211

FIGURE A3.30- PRPE 5-3-1 ZO-1 Analysis

212

FIGURE A3.31- PRPE 10-1-1 (5/17/13)

213

FIGURE A3.32- PRPE 10-1-1 ZO-1 Analysis
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FIGURE A3.33- PRPE 10-2-1 (5/17/13)
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FIGURE A3.34- PRPE 10-2-1 ZO-1 Analysis
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FIGURE A3.35- PRPE 10-3-1 (6/1/13)

217

FIGURE A3.36- PRPE 10-3-1 ZO-1 Analysis
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FIGURE A3.37- PRPE 10-4-1 (6/1/13)

219

FIGURE A3.38- PRPE 10-4-1 ZO-1 Analysis
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FIGURE A3.39- PRPE 20-1-1 (5/17/13)
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FIGURE A3.40- PRPE 20-1-1 ZO-1 Analysis
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FIGURE A3.41- PRPE 20-1-3 (6/1/13)
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FIGURE A3.42- PRPE 20-1-3 ZO-1 Analysis
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FIGURE A3.43- PRPE 20-3-1 (6/1/13)
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FIGURE A3.44- PRPE 20-3-1 ZO-1 Analysis
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FIGURE A3.45- PRPE FN-1-1 (5/17/13)
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FIGURE A3.46- PRPE FN-1-1 ZO-1 Analysis
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FIGURE A3.47- PRPE FN-2-1 (5/17/13)
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FIGURE A3.48- PRPE FN-2-1 ZO-1 Analysis
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FIGURE A3.49- PRPE FN-1-2 (6/1/13)
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FIGURE A3.50- PRPE FN-1-2 ZO-1 Analysis
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FIGURE A3.51- PRPE FN-2-2 (6/1/13)
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FIGURE A2.52- PRPE FN-2-2 ZO-1 Analysis
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